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Abstract 
Healthy adult aging is associated with sarcopenia; a loss of skeletal muscle mass known as.  
Major contributors to this process include functional and morphological changes in the 
contractile tissue and within the neuromuscular system.  Currently, the relationship between 
muscle mass, normalized strength, structural integrity, and neuromuscular properties [such as 
motor unit number estimates (MUNE)], in the tibialis anterior (TA) with aging is largely 
unknown.  Therefore, to examine this relationship we recruited twelve young (25 ± 3 years 
old), six old (68 ± 5 years old) and six very old (79 ± 3 years old) men.  Magnetic resonance 
(MR) images were obtained from the entire musculature of the leg from the tibial plateau to 
the malleoli.  Muscle cross-sectional areas (CSA) were calculated using image processing 
software.  Strength was measured as maximal isometric voluntary dorsiflexion contraction 
(MVC) torque; this was then normalized to CSA.  Structural integrity of the muscle was 
evaluated by magnetization transfer ratio (MTR) using magnetic resonance imaging (MRI).  
Neuromuscular measures were also collected and decomposition-enhanced spike-triggered 
averaging was used to collect surface and intramuscular electromyography (EMG) signals.  
From these data, estimates of motor unit numbers were made.  Muscle CSA was less only in 
the very old (11.2cm
2
), no differences existed between the young (13.4cm
2
) and old 
(11.7cm
2
).  Strength was ~26% lower in the old and ~24% in the very old than the young.  
When strength was normalized to CSA there were no differences between the groups.  Very 
old men had ~8% lower MTR values than the young and old men, with no differences 
between young and old.  Neuromuscular measures, specifically the combination of a 
decreased compound muscle action potential (CMAP) and increased surface motor unit 
potential (SMUP), resulted in a decrease in MUNE between young [~147 motor units (MU)] 
and old (~109 MUs) and also between young and very old (~80 MUs).  In conclusion, 
muscular structure and function appear to be maintained in the older adult due to 
compensatory motor unit remodeling; however in the very old adult the structural integrity of 
the muscle becomes compromised as motor unit losses are greater resulting in the 
acceleration of sarcopenia. 
Keywords:   muscle, aging, normalized strength, magnetic resonance imaging 
magnetization transfer ratio, motor unit number estimates, neuromuscular 
 iv 
 
Acknowledgments 
I would like to express my appreciation to my supervisor Dr. Greg D Marsh.  From start to 
finish he has been an ideal supervisor and it has been a pleasure working with him. 
This thesis would not have been possible without my fellow researchers in the 
Neuromuscular Laboratory at The University of Western Ontario: Matti Allen, Geoffrey 
Power, Dr. Brian Dalton, Brad Harwood, Cameron Smith, Justin Paturel, Dennis Choi, and 
especially Dr. Charles Rice.  Thank you for not only sharing your advice and expertise but 
also your laboratory with me.  It is a wonderful environment to work in.  I would also like to 
thank John Butler for his valuable MRI technical assistance. 
Thank you to all of my participants, the Retired Research Association, the Canadian Centre 
for Activity and Aging, and St. Joseph’s Health Care.  This research was supported by 
funding from Lawson Health Research Institute and The Natural Sciences and Engineering 
Research Council of Canada. 
I would like to thank Jenn Plaskett and Jacqui Sanders for their kindness, patience, 
organization, and helpfulness throughout my Masters degree.  
A special thank you to my parents, Darwin and Janna, and the rest of my family for their 
support and guidance.  Thank you for guiding me in the right direction and helping me 
discover something I love doing. 
Alisha, I am grateful for you.  Every day you push me to be my best.  Thank you for your 
unconditional love and support.  You are my everything.  I love you. 
 v 
 
Table of Contents 
CERTIFICATE OF EXAMINATION ........................................................................... ii 
Abstract .............................................................................................................................. iii 
Acknowledgments.............................................................................................................. iv 
Table of Contents ................................................................................................................ v 
List of Tables ................................................................................................................... viii 
List of Figures .................................................................................................................... ix 
List of Abbreviations and Symbols..................................................................................... x 
List of Appendices ............................................................................................................. xi 
Chapter 1 ............................................................................................................................. 1 
1 Introduction .................................................................................................................... 1 
1.1 Purpose .................................................................................................................... 3 
1.2 Hypothesis............................................................................................................... 4 
Chapter 2 ............................................................................................................................. 6 
2 Literature Review ........................................................................................................... 6 
2.1 Sarcopenia ............................................................................................................... 6 
2.2 Causes and Effects of Sarcopenia ........................................................................... 6 
2.2.1 Physical Activity ......................................................................................... 8 
2.2.2 Nutritional Status ...................................................................................... 10 
2.2.3 Neuromuscular Adaptations...................................................................... 12 
2.2.4 Hormonal Changes.................................................................................... 13 
2.3 Measuring Sarcopenia ........................................................................................... 15 
2.3.1 Muscle Quantity ........................................................................................ 15 
2.3.1.1 CSA ............................................................................................ 15 
2.3.1.2 CSA Composition ....................................................................... 16 
 vi 
 
2.3.1.3 Volume ....................................................................................... 17 
2.3.2 Muscle Quality .......................................................................................... 18 
2.3.2.1 Normalized Strength ................................................................... 18 
2.3.2.2 MTR ........................................................................................... 19 
2.3.2.3 Neuromuscular Measures ........................................................... 20 
2.4 Prevalence of Sarcopenia ...................................................................................... 20 
2.5 Preventing Sarcopenia .......................................................................................... 21 
Chapter 3 ........................................................................................................................... 23 
3 Methods ........................................................................................................................ 23 
3.1 Participants ............................................................................................................ 23 
3.2 MRI ....................................................................................................................... 23 
3.3 Muscle Quantity .................................................................................................... 24 
3.3.1 CSA, CSA Composition & Volume ......................................................... 24 
3.4 Muscle Quality ...................................................................................................... 24 
3.4.1 Normalized Strength ................................................................................. 24 
3.4.2 MTR .......................................................................................................... 25 
3.4.3 Neuromuscular Properties ......................................................................... 26 
3.5 Statistics ................................................................................................................ 28 
Chapter 4 ........................................................................................................................... 29 
4 Results .......................................................................................................................... 29 
4.1 Participant Characteristics .................................................................................... 29 
4.2 MR Sample Images ............................................................................................... 29 
4.3 Muscle Quantity .................................................................................................... 30 
4.3.1 CSA, CSA Composition, & Volume ........................................................ 30 
4.4 Muscle Quality ...................................................................................................... 32 
4.4.1 Normalized Strength ................................................................................. 32 
 vii 
 
4.4.2 MTR .......................................................................................................... 33 
4.4.3 Neuromuscular Properties ......................................................................... 34 
Chapter 5 ........................................................................................................................... 37 
5 Discussion .................................................................................................................... 37 
5.1 Summary ............................................................................................................... 41 
5.2 Conclusions ........................................................................................................... 42 
5.3 Strengths of the Study ........................................................................................... 42 
5.4 Limitations of the Study........................................................................................ 43 
5.5 Future Directions .................................................................................................. 44 
References ......................................................................................................................... 46 
Appendices ........................................................................................................................ 74 
Curriculum Vitae .............................................................................................................. 77 
 
 viii 
 
List of Tables 
Table 1: Participant characteristics. ........................................................................................ 29 
Table 2: CSA & CSA composition. ........................................................................................ 30 
Table 3: Strength and normalized strength values for the TA. ............................................... 32 
Table 4: Neuromuscular properties of the TA. ....................................................................... 34 
 
 ix 
 
List of Figures 
Figure 1: Isometric strength and neuromuscular properties experimental setup. ................... 25 
Figure 2: Representative MR images of the right leg of young, old, and very old participants 
including a sample outline of a ROI in white. ........................................................................ 30 
Figure 3: CSA composition as a percent of total CSA in the young, old, and very old men.  
*significantly different than young (P < 0.05). ...................................................................... 31 
Figure 4: Muscle volume in young, old, and very old men. *significantly different than 
young (P < 0.05). .................................................................................................................... 31 
Figure 5: Strength normalized to total CSA and muscle CSA. *significantly different than 
young (P < 0.05). .................................................................................................................... 32 
Figure 6: Absolute muscle volume to strength normalized to volume.  *significantly different 
volume than young (P < 0.05). ............................................................................................... 33 
Figure 7: Magnetization transfer ratios young, old, and very old men. *significantly different 
than young, †significantly different than old (P < 0.05)......................................................... 34 
Figure 8: Compound muscle action potentials (A) and surface motor unit potentials (B) of the 
young, old, and very old men. *significantly different than old (P < 0.05). .......................... 35 
Figure 9: Motor unit number estimates for young, old, and very old men. *significantly 
different than young (P < 0.05)............................................................................................... 36 
Figure 10: Predictive timeline of sarcopenia.  MTR declines may precede normalized 
strength declines...................................................................................................................... 39 
Figure 11: Percent changes from young compared to old and very old men in the measures of 
muscle quality.  *significantly different than young (P < 0.05). ............................................ 40 
 
 x 
 
List of Abbreviations and Symbols 
ANOVA analysis of variance 
CMAP compound muscle action potential 
CSA cross-sectional area 
DE-STA decomposition enhanced spike triggered averaging 
DEXA dual-energy X-ray absorptiometry 
EMG electromyography 
IGF-1 insulin-like growth factor-1 
MR magnetic resonance 
MRI magnetic resonance imaging 
MT magnetization transfer 
MTR magnetization transfer ratio 
MU motor unit 
MUNE motor unit number estimates 
MUP motor unit potential 
MVC maximum voluntary contraction 
ROI region of interest 
SMUP surface motor unit potential 
TA tibialis anterior 
 
 xi 
 
List of Appendices 
Appendix A: MRI Subject Screening Questionnaire. ............................................................. 74 
Appendix B: UWO Ethics Approval for MRI Research on Humans. .................................... 75 
Appendix C: UWO Ethics Approval for Neuromuscular Research on Humans. ................... 76 
1 
 
Chapter 1  
1 Introduction 
Sarcopenia is a non-pathological process characterized by the progressive loss of skeletal 
muscle mass, strength, and function associated with natural adult aging (Doherty, 2003; 
Rosenberg, 1989).  In cross-sectional studies involving adults, sarcopenia has been found 
to be a gradual process until the seventh or eighth decade of life, at which point there is 
an accelerated loss of muscle mass (Doherty, 2003; Lexell, Taylor, & Sjostrom, 1988; 
Narici & Maffulli, 2010).  Muscular strength is well-maintained until the seventh decade 
of life (W. F. Brown, Strong & Snow, 1988; Candow & Chilibeck, 2005; Murga Oporto, 
Menendez-de Leon, Bauzano Poley, & Nunez-Castain, 2003), but at a certain point in the 
aging process, not only does muscle mass decline, but also muscle quality.  The loss of 
strength has been found to be accompanied by decreases in muscle mass (Frontera, 
Hughes, et al., 2000; Frontera et al., 2008; Jubrias, Odderson, Esselman, & Conley, 1997; 
Klein, Rice, & Marsh, 2001; Young, Stokes, & Crowe, 1985).  However, the changes in 
muscle quantity alone do not always explain the decreases in strength.  Reduced muscle 
quality with age may also be a significant contributor to the loss of strength (Newman et 
al., 2003). 
Quantitative decreases in muscle mass can be examined using magnetic resonance 
imaging (MRI).  Magnetic resonance imaging is a valuable non-invasive tool that has 
been used extensively for assessing muscle structure.  Magnetic resonance imaging 
allows the observation of changes in muscle cross-sectional area (CSA), the ratio of 
contractile to non-contractile tissue, and muscle volume. 
Muscle quality has previously been assessed through invasive methods such as muscle 
biopsy (Frontera, Hughes, et al., 2000; Frontera, Meredith, O’Reilly, Knuttgen, & Evans, 
1988).  Not only is muscle biopsy invasive, but it also introduces a high amount of 
variability as it samples just a small portion of the whole muscle (Evans & Coggan, 
1995).  Muscle quality using a combination of noninvasive measures has not been well 
studied.  Muscle quality can be evaluated noninvasively in several ways.  Three of these 
methods include normalized strength [strength per unit of muscle mass (e.g. CSA)], 
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magnetization transfer ratios (MTR), and neuromuscular evaluations such as 
electromyography (EMG) measures. 
Normalized strength represents the torque per unit of muscle mass and therefore gives a 
measure of the ability of the muscle tissue to contract.  Using normalized strength to 
gauge muscle quality accounts for age-related absolute loss of contractile tissue and the 
infiltration of noncontractile tissue within the muscle.  Eliminating any noncontractile 
tissue from the CSA measurement allows for a relative comparison of just the contractile 
tissue and the strength of the muscle and therefore comparisons between age groups can 
be made solely on the amount of contractile tissue per se.  Measuring normalized strength 
is a fairly simple process in which a maximum voluntary contraction (MVC) is 
performed to measure maximal isometric torque and a measurement of CSA is taken 
(either by using ultrasound, computed tomography, or MRI) and the torque value is then 
normalized to the CSA (MVC/CSA).  
Magnetization transfer (MT) has not been widely utilized to examine healthy muscle 
across aged populations.  Previously, MTR has been used primarily in the 
characterization of white matter disease in the brain (e.g. multiple sclerosis) (Henkelman, 
Stanisz, & Graham, 2001).  Recently, Sinclair et al. (2012) examined skeletal muscle 
MTR and found a significant decrease in patients with clinical peripheral neuropathies.  
Magnetization transfer is based on longitudinal magnetization interaction between free 
protons and macromolecular (bound) protons.  Normally, the protons associated with 
macromolecules such as protein are not visible in MRI due to their short T2 relaxation 
time.  By presaturating the protons associated with macromolecules via an off-resonance 
pulse the excitation is transferred to the free protons decreasing the net magnetization.  
The magnitude of the MT is dependent on the tissue imaged; skeletal muscle normally 
has a prominent MT effect (Sinclair et al., 2012) because of the high concentration of 
protein in muscle tissue.  A lower MTR indicates reduced capacity of the macromolecular 
protons to exchange MT with free protons and therefore reflects decreased structural 
integrity in muscle (McDaniel et al., 1999; Schwenzer et al., 2009). 
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Evaluating muscle quality in terms of the neuromuscular system examines the 
electrophysiologic properties of excitable muscle mass such as compound muscle action 
potential (CMAP) values, contraction durations, and the number of functioning motor 
units (MUs) (Tomlinson & Irving, 1977).  The concept of age-related MU remodeling 
indicates that due to collateral reinnervation there is a moderate preservation of muscle 
mass until the eighth or ninth decades of life (W. F. Brown, 1972; W. F. Brown et al., 
1988; Campbell, McComas, & Petito, 1973; Doherty, 2003; Gordon, Hegedus, & Tam, 
2004; McNeil, Doherty, Stashuk, & Rice, 2005b).  Collateral reinnervation is 
characterized by an axon sprout from a healthy MU ‘recapturing’ an orphaned muscle 
fiber when the constituent motor neuron dies thus retaining the majority of muscle fibers 
and therefore a minimal amount of muscle mass is lost.  Typically, collateral 
reinnervation involves type II MUs dying and being reinnervated by slower type I MUs 
and results in larger MUs (more muscle fibers per single MU).  With continued aging, the 
combination of an increased rate of MU death and larger MUs results in a higher number 
of muscle fibers being lost, thus explaining the accelerated loss of muscle mass in very 
old adults.  The number of functioning MUs in a human muscle group can be estimated 
electrophysiologically by dividing the compound muscle action potential (CMAP) in 
response to maximal stimulation of its motor nerve (CMAP; maximal size of the entire 
MU pool within the muscle group) by the corresponding size parameter of the mean 
surface detected MU potentials [surface motor unit potential (SMUP); average size of the 
MU within a given muscle group] (Bromberg, 2007). 
Overall, two major contributors to the resultant loss of strength with adult aging are 
changes in muscle quantity, such as CSA, CSA composition, and volume; and a decrease 
in muscle quality, such as normalized strength, MTRs and neuromuscular properties (e.g. 
MUNE). 
1.1 Purpose 
The purpose of this study was to explore the progression of sarcopenia and the loss of 
strength through both the quantitative and qualitative age-related changes in muscle in a 
young, old, and very old population of men.   
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To examine muscle quantity, CSA, CSA composition, and muscle volumes of the tibialis 
anterior (TA) were analyzed using MRI.  To examine muscle quality, normalized strength 
(isometric strength relative to CSA), MTRs, and neuromuscular measures such as CMAP, 
contraction duration, SMUP and motor unit number estimates (MUNE), in the TA were 
examined. 
Therefore, the following research questions were addressed in this study: 
1.  How does muscle quantity, including CSA, CSA composition, and muscle 
volume, differ between young, old, and very old populations of men? 
2. How does muscle quality, such as normalized strength, MTR, and neuromuscular 
measures, differ between young, old, and very old populations of men? 
3. Is there an ideal measure of muscle quality that reflects muscle function? 
4. Does muscle quantity affect muscle quality or does muscle quality affect muscle 
quantity? 
1.2 Hypothesis 
In response to the research questions the following hypotheses were tested: 
1. Muscle quantity will decrease among the three age groups.  Total CSA will not 
change across the three groups, however in the old and very old men there will be 
an increase in noncontractile tissue and a decrease in contractile tissue in the TA 
compared to the young men.  This increase in noncontractile tissue and decrease 
in contractile tissue will result in decreased viable muscle volume. 
2. Muscle quality changes will be dependent on the evaluation technique across the 
three age groups.  Strength will concurrently decrease with CSA resulting in 
normalized strength measures showing no differences.  Magnetization transfer 
ratios will show a decrease as the structural integrity decreases in the protein with 
increasing age.  The neuromuscular measures will reflect the decreases in the 
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excitable muscle mass (i.e. CMAP and SMUP) meaning a decreased number of 
estimated MUs in the old and very old men. 
3. All three measures of muscle quality will be related to muscle function.  Each 
measure will have advantages and disadvantages. 
4. Muscle quantity will be maintained in the old men due to collateral mechanisms 
maintaining muscle quality, however in the very old men these compensatory 
mechanisms will no longer be able to keep up and muscle mass will decrease. 
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Chapter 2  
2 Literature Review 
2.1 Sarcopenia 
Sarcopenia, a term of Greek origin introduced by Rosenberg in 1989, meaning poverty of 
flesh, refers to the loss of skeletal muscle mass associated with natural aging.  However, 
the multidimensional nature of sarcopenia necessitates a broader definition that 
incorporates both the quantitative and qualitative properties of the sarcopenic process 
(Cesari, Ferrini, Zamboni, & Pahor, 2008).  Consequently, the current definition in the 
research has evolved to encompass the loss of skeletal muscle mass, strength, contractile 
quality, and the resultant functional decline (Berger & Doherty, 2010).  The causation of 
sarcopenia is a result of a combination of behavioral, biological, and environmental 
factors thus it would vary considerably among individuals.  Generally, sarcopenia is a 
gradual process beginning after the third decade of life and accelerating after the seventh 
decade of life (Waters, Baumgartner, & Garry, 2000). 
Although there is no specific level of muscle mass at which sarcopenia is considered to 
be present (Roubenoff, 2001), the relationship between muscle mass and strength makes 
any loss of muscle mass consequential (Roth, Ferrell, & Hurley, 2000).  Currently, there 
is no universal diagnosis criterion for sarcopenia, but a common definition of sarcopenia 
was proposed by Janssen, Heymsfield, & Ross (2002) that is based on two categories of 
sarcopenia.  Individuals with grade I sarcopenia have an appendicular skeletal muscle 
mass-to-body height ratio between -1 and -2 standard deviations from the gender-specific 
mean value of young controls.  Grade II sarcopenia individuals are at least -2 standard 
deviations below this gender-specific value of young controls.  Another definition of 
sarcopenia uses a percentage of skeletal muscle mass index (SMI%, total muscle 
mass/body mass x 100%) (Janssen, Heymsfield, Wang, & Ross, 2000). 
2.2  Causes and Effects of Sarcopenia 
Although the exact cause of sarcopenia is unknown; physical inactivity, alterations in the 
central and peripheral nervous systems, altered hormonal levels, and decreased energy 
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and protein intake are believed to be four main factors involved in the process (Doherty, 
2003).  Although there are numerous other factors involved in the progression of 
sarcopenia, these four are believe to be major contributing factors to the characteristic 
skeletal muscle atrophy and weakness due to sarcopenia contributing to the loss of 
functional mobility, loss of independence, and frailty present in many older adults 
(Roubenoff, 2000a, 2001). 
Sarcopenia has been related to limited function, frailty, and an increased risk of morbidity 
and mortality (Bales & Ritchie, 2002; Fried et al., 2001; Janssen et al., 2002).  Sarcopenia 
has also been linked to osteoporosis (Coin et al., 2000), insulin resistance (Boyle et al., 
2001; Cefalu et al., 1995), obesity (Cesari et al., 2005 Roubenoff, 2000c), and arthritis 
(Toda & Kobayashi, 2000; Walsmith & Roubenoff, 2002).  The sarcopenic loss of 
muscle mass leads to a loss of strength which leads to a loss of power and results in 
fragility and disability (Hairi et al., 2010; Muhlberg & Sieber, 2004). 
Sarcopenia has been proposed to be associated with a reduction in both muscle fiber size 
and number.  In the elderly, type II muscle fiber area is reduced by ~20% to ~50% 
whereas type I fibers are reduced ~1% to ~25% (Lexell & Downham, 1992; Lexell et al., 
1988; Roos, Rice, & Vandervoort, 1997).  Muscle fiber numbers were found to be more 
equally affected, as by the ninth decade of life there was found to be ~50% fewer type I 
and type II fibers when compared to a young counterpart (Lexell, 1993; Lexell et al., 
1988).  From this, it is believed that motor neuron loss may be a leading cause in age-
related muscle atrophy (Doherty & Brown, 2002; Doherty, Vandervoort, & Brown, 1993; 
Doherty, Vandervoort, Taylor, & Brown, 1993).  Possible supporting evidence and 
agreement for this conclusion are apparent in electrophysiological studies that examine 
the neuromuscular properties of the muscle and estimate the number of functioning MUs 
within the muscle (Doherty et al., 1995; McNeil et al., 2005b).  Motor unit number 
estimation studies have found that with age it appears likely that there is a remodeling of 
MUs from type II to predominately type I (W. F. Brown, 1972; W. F. Brown et al., 1988; 
Campbell et al., 1973; Doherty, 2003; Gordon et al., 2004; McNeil et al., 2005b).  This 
remodeling of MUs from type II to type I results in decreased strength and slower 
reaction times, leaving the individual with a limited ability to recover from potential falls 
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(Muhlberg & Sieber, 2004).  As the individual continues to age and MUs continue to 
remodel, a greater number of muscle fibers are lost placing the individual in a condition 
even more susceptible to falls and fractures (Tinetti, 2003).  Previous studies have found 
an increase in the rate of falls and injury in the elderly (Fried et al., 2001; Vellas, Wayne, 
Garry, & Baumgartner, 1998).  Decreased reaction time may affect the ability of the 
individual to not only prevent falls and injury (Pai & Bhatt, 2007; Skelton, Kennedy, & 
Rutherford, 2002), but it may also limit their independence (Doherty, 2003; Roubenoff, 
2000b, 2001).  Some current research suggests that in some cases, sarcopenia is part of a 
cyclic process involving this loss of independence and a continual progression of 
sarcopenic symptoms.  The cycle consists of age-related changes impairing the 
neuromuscular system which in turn results in a higher incidence of falls and fractures 
which leaves the individuals immobile.  Immobilization causes a decline of nutritional 
status [subsequently explained by the “empty refrigerator” problem (Boumendjel, 
Herrmann, Girod, Sieber, & Rapin, 2000)] which results in malnutrition.  Malnutrition 
impairs protein synthesis, therefore declining the protein reserve of the body which 
diminishes the capacity to meet the extra demand of protein synthesis associated with 
disease and injury.  This results in further decreases in activity and mobility (Muhlberg & 
Sieber, 2004); decreases in activity and mobility then result in an even greater decline in 
muscle function (Bauer, Kaiser, & Sieber, 2008; Janssen et al., 2002) and consequently 
furthers sarcopenia processes (Muhlberg & Sieber, 2004). 
2.2.1 Physical Activity 
Physical inactivity is a significant contributor to sarcopenia.  The relationship in older 
individuals between physical activity levels, disability, and skeletal muscle mass has been 
well established (Evans, 1997, 2002; Porter, Vandervoort, & Lexell, 1995). 
Elderly individuals who are physically inactive will experience a greater decline in 
muscle mass than those elderly individuals who are physically active (Roubenoff, 
2000b).  This loss may be attributed to a reduction in intensive physical loading (Power et 
al., 2012; Power et al., 2010).  However, not just engaging in physical activity is 
adequate, but the physical activity must be of sufficient intensity and duration to recruit 
type II muscle fibers as not recruiting these fibers results in type II fiber atrophy and the 
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development of sarcopenia (Roubenoff, 2000b).  Others have found a dose-dependent 
increase in lean mass and physical function following acute resistance exercise (He, 
Goodpaster, & Kelley, 2004; Hillsdon, Brunner, Guralnik, & Marmot, 2005; Leveille, 
Guralnik, Ferrucci, & Langlois, 1999; Manini et al., 2009). 
The physiological benefits of resistance exercise for the elderly are numerous.  Some of 
these benefits include hypertrophy (Charette et al., 1991), reduced inflammation (Greiwe, 
Cheng, Rubin, Yarasheski, & Semenkovich, 2001), increased mitochondrial function 
(Melov, Tarnopolsky, Beckman, Felkey, & Hubbard, 2007), improved myogenic 
signaling (Kosek, Kim, Petrella, Cross, & Bamman, 2006), and increased satellite cell 
activity (Roth et al., 2001).  Acute resistance exercise alone has been shown to be 
effective in increasing muscle mass and strength in sedentary individuals even in the 
ninth decade of life (Fiatarone et al., 1994).  Following an acute bout of resistance 
training, the increase in muscle mass and strength has been found to be maintained with 
only a once a week continued resistance training program (Trappe, Williamson, & 
Godard, 2002). 
Complementary to these resistance training results, recent studies have also found that 
acute aerobic exercise is assistive in the maintenance of muscle mass with age 
(Chomentowski et al., 2009).  Aerobic exercise is beneficial through the mechanisms of 
improved muscle blood flow (DeSouza et al., 2000), decreased oxidative stress (Bloomer, 
Goldfarb, Wideman, McKenzie, & Consitt, 2005), and decreased glucocorticoid 
sensitivity (Duclos, Corcuff, Pehourcq, & Tabarin, 2001).  
Chronic training effects have been studied with aging through the examination of Masters 
athletes.  These individuals have a life-long history of physical activity and therefore 
provide insight into the effects of life-long training on the muscular system.  As well, 
comparison can be made between these Masters athletes and sedentary older individuals, 
potentially highlighting the benefits and potential prevention of sarcopenia with a chronic 
physical activity regime (Hawkins, Wiswell, & Marcell, 2003).  From these studies on 
Masters athletes, it would appear that the preservation of muscle mass, strength, and 
neuromuscular properties is use-dependent.  Power et al. (2010) found that there was a 
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preservation of MUs in the active muscles in Masters runners, but not in the less active 
muscles.  Motor unit number estimates in the TA of the Masters runners was similar to 
young, however the MUNE of a less active arm muscle (biceps brachii) were similar in 
Masters runners and their old, less active counterparts, both being less than young (Power 
et al., 2012).  In contrast to the usage preservation theory, Pearson et al. (2002) found 
similar declines in Master weightlifters and sedentary controls for both peak power (1.3% 
vs. 1.2%) and force (0.6% vs. 0.5%).  However, the declines in absolute differences 
allowed an ~85 year old to perform similar to an ~65 year old. 
2.2.2 Nutritional Status 
A decline in food intake has been found to be associated with aging (Morley, 
Baumgartner, Roubenoff, Mayer, & Nair, 2001).  Many factors are believed to contribute 
to decreased food intake in the elderly including loss of appetite, gastrointestinal changes, 
altered taste and smell, social changes, and economic limitations (Bales & Ritchie, 2002).  
Inadequate nutritional intake of many elderly individuals is of concern in regards to the 
development of sarcopenia (Visvanathan & Chapman, 2009).  In particular, insufficient 
protein intake may lead to the development of sarcopenia through a lack of amino acid 
availability and a subsequent decrease in muscle protein synthesis (V. R. Young, 1990).  
As a result, insufficient protein intake appears to be a critical factor for sarcopenia 
development in older adults and may severely compromise quality of life (Vetta, 
Ronzoni, Taglieri, & Bollea, 1999). 
Recent data indicate that lean mass in older adults is significantly and positively 
associated with protein intake (Houston et al., 2008).  However, it is estimated that only 
15% of individuals over the age of 60 are consuming more than 75% of the 0.8g/kg/day 
recommend daily allowance of protein (Roubenoff & Hughes, 2000).  Furthermore, it has 
been found that eating equal to or less than the recommend dietary allowance of protein 
still leads to substantial declines in muscle strength (Castaneda, Charnley, Evans, & 
Crim, 1995).  Therefore, questions have been raised as to the adequacy of the 
recommendation levels of daily protein intake.  In a study by Houston et al. (2008), over 
the course of three years, individuals who consumed more than the recommended dietary 
allowance for protein experienced the smallest losses of lean mass, whereas the 
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individuals who consumed protein quantities at or below the recommended daily 
allowance experienced significant muscle atrophy.  This suggests that daily intake for 
protein in the elderly is below adequate levels to maintain optimal muscle health with 
aging (Evans et al., 2008; Morais, Chevalier, & Gougeon, 2006; Sood, Baker, & 
Coleman, 2008). 
Protein synthesis may be maximized in older adults by supplementing meals with 
essential amino acids.  Essential amino acids such as leucine, isoleucine, and valine are 
critical for protein synthesis in older adults (Anthony et al., 2002; Combaret et al., 2009; 
Dillon et al., 2009; Henderson, Irving, & Nair, 2009; Holecek, Sprongl, Tilser, & Tichy, 
2001; Katsanos, Kobayashi, Sheffield-Moore, Aarsland, & Wolfe, 2006).  Protein 
synthesis has also been found to decline in the elderly when protein is ingested in 
conjunction with carbohydrates (Volpi, Mittendorfer, Rasmussen, & Wolfe, 2000).  
Subsequently, Paddon-Jones & Rasmussen (2009) suggested that more protein be 
consumed with each meal in the elderly, so that there is an increase of daily overall 
protein intake. 
The quantity and quality of protein in the body is not only affected by the decreased 
protein intake but is also determined through a continuous process involving a balance 
between protein breakdown and protein synthesis, termed protein turnover (Holloszy & 
Nair, 1995).  Research reports that muscle protein synthesis rates are generally lower in 
the old when compared to young (Hasten, Pak-Loduca, Obert, & Yarasheski, 2000; 
Holloszy & Nair, 1995; Roth et al., 2000; Yarasheski, Zachwieja, Campbell, & Bier, 
1995).  Balagopal, Rooyrackers, Adey, Ades, & Nair (1997) compared protein synthesis 
rates in individuals in the third, sixth, and eighth decades of life and found that the rate of 
protein synthesis was significantly decreased by the sixth decade of life and continued to 
decline with age.  With age, this protein turnover balance reflects a shift of a decreased 
synthesis rate rather than an increased catabolic rate (Combaret et al., 2009; Morley, 
2012; Ryanzanov & Nefsky, 2002; Vandervoort & Symons, 2001). 
Alterations of muscle protein turnover could represent an early and sensitive marker of 
sarcopenia (Abellan van Kan et al., 2011).  The loss of muscle mass and strength with 
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aging is associated with the loss of skeletal muscle proteins and alterations in the balance 
between protein synthesis and degradation.  In general, regardless of the mechanisms, 
muscle atrophy occurs when protein breakdown exceeds synthesis. A proper diet is 
critically important to slowing sarcopenia progression, as well as in maintaining overall 
healthy aging (Houston et al., 2008; Paddon-Jones & Rasmussen, 2009).  
2.2.3 Neuromuscular Adaptations 
Age-related changes in the neuromuscular system play a significant role in the onset of 
sarcopenia.  The neuromuscular system consists of muscles and the nerves that control 
them.  A motor neuron is an electrically excitable cell located in the central nervous 
system that projects axons outside the central nervous system and is responsible for 
sending signals to the muscles to initiate movement.  A MU is a single motor neuron and 
all of the corresponding muscle fibers the neuron innervates.  The number of fibers in a 
MU depends on the specific muscle and the general function of the muscle.  Although 
muscles have mixed muscle fiber content, each motor neuron innervates the same muscle 
fiber type (Burke, Levine, Tsairis, & Zajac, 1973). 
With age, motor neurons die and subsequently, the number of functioning MUs decline 
(Roth et al., 2000, Roubenoff 2001).  The loss of muscle fibers begins with this loss of 
motor neurons; as motor neurons die, muscle fibers belonging to the MU become 
denervated.  When a motor neuron dies, an adjacent motor neuron, usually a type I motor 
neuron, may reinnervate these muscle fibers, preventing atrophy.  This process is called 
motor unit remodeling.  However, not all denervated muscle fibers are reinnervated and 
some muscle fibers atrophy leading to a decrease in muscle mass (Roth et al., 2000).  
This is a continuous process throughout life and is considered irreversible (Roubenoff, 
2001).  When compared to type II MUs, type I MUs have slower firing rates, are slower 
to contract, produce less muscle force, and are smaller in size and fiber number 
(Henneman, 1985; De Luca & Hostage, 2010). Therefore, MU remodeling by type I 
motor neurons leads to less efficient MUs.  The remodeled type I MU will be larger and 
have less precise control of movements, less force production and, the velocity of the 
muscle contraction will slow (Baudry, Klass, & Duchateau, 2005; Roth et al., 2000; 
Roubenoff, 2001; Waters et al., 2000).  This helps explain the loss of balance and speed 
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of movement with age.  In addition, with continued aging, larger MUs will die and 
denervation rates will exceed reinnervation rates, further explaining the increased rate of 
atrophy of muscle fibers and overall decrease in muscle mass in the elderly (Roth et al., 
2000). 
Electrophysiological studies have demonstrated the loss of whole functioning MUs in 
proximal and distal muscles in the upper and lower extremities (de Koning et al., 1988; 
McComas, 1991; Stalberg, 1980). For example, lower reported MUNE have been found 
in the thenar, TA, and biceps brachii muscle groups (W. F. Brown, 1972; Doherty & 
Brown, 1993, 1997; McNeil et al., 2005b; Power et al., 2012; Power et al., 2010) with 
age and are consistent with anatomic data that has demonstrated losses of anterior horn 
cells and ventral root fibers with aging (Mittal & Logmani, 1987; Tomlinson & Irving, 
1977).  Cross-sectional studies suggest that MU numbers are well maintained until the 
seventh decade of life and thereafter begin to decline precipitously (McComas, 1991; 
McNeil et al., 2005b). 
Various causes for motor neuron death have been suggested, among which, on the basis 
of recent data in aged animals, is a crucial role of the neuromuscular junction (NMJ) 
(Abellan van Kan et al., 2011).  Some researchers also propose that human nerve cells 
have a predetermined life span and the decline in quantity of these cells is dependent on 
the location in the body, age, and presence of disease (Vandervoort & Symons, 2001). 
With regards to the neuromuscular system, the causation of sarcopenia is complex 
involving both central and peripheral nervous system alterations (Narici & Maffulli, 
2010).  Throughout the life span, muscle undergoes a continuous cycle of denervation 
and reinnervation, but in old age it seems that the process of reinnervation cannot keep 
pace with that of denervation, contributing to the loss of MUs and muscle atrophy. 
2.2.4 Hormonal Changes 
Aging is associated with several changes in hormonal levels, including a decrease in the 
concentrations of testosterone, growth hormone, and insulin-like growth factor-1 (IGF-1) 
(Hameed, Harridge, & Goldspink, 2002; Kamel, Maas, & Duthie, 2002).  A sustained 
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decrease in these hormones is linked to a decrease in muscle mass and an increase in 
body fat (Waters et al., 2000).  Testosterone, growth hormone, and IGF-1 are influential 
in the regulation of protein turnover; specifically, protein synthesis rates (Griggs et al., 
1989), especially of myosin heavy chain and myofibrillar protein (Waters et al., 2000). 
With age, there is a reduction in levels of both total testosterone and free testosterone 
(Morley et al., 2001; J. L. Tenover, 1997; J. S. Tenover, Matsumoto, Plymate, & 
Bremner, 1987).  Vermeulen & Kaufman (1995) found that between the ages of 20 to 80 
years old, total testosterone decreased by ~35% whereas free testosterone was reduced by 
~50%.  Epidemiological data support the relationship between the decline in testosterone 
and the decline in muscle mass (Vermeulen, Goemaere, & Kaufman, 1999), strength 
(Baumgartner, Waters, Gallagher, Morley, & Garry, 1999), and functional status (Perry, 
Miller, Patrick, & Morley, 2000).  Iranmanesh, Lizarralde, & Veldhuis (1991) sampled 
and analyzed the blood of men between the ages of 21 and 71 for 24 hours and found 
growth hormone concentrations are also approximately halved between young and old 
individuals.  Growth hormone mediates its effects on muscle by regulating the synthesis 
of IGF-1 (Sara & Hall, 1990) which is also decreased with age (Hennessey et al., 2001; 
Morley, Haren, Kim, Kevorkian, & Perry, 2005).   
Some research has shown that hormone administration in pharmacological doses does 
increase muscle mass and strength (Gotherstrom et al., 2009; Johannsson, Grimby, 
Sunnerhagen, & Bengtsson, 1997; Sattler et al., 2009).  Supplemental testosterone has 
been found to produce significant gains in total and appendicular lean mass, muscle 
strength, and aerobic endurance with significant reductions in whole-body and trunk fat 
(Sattler et al., 2009).  Gotherstrom et al. (2009) found that with 10 years of growth 
hormone replacement therapy, there was increased muscle strength during the first five 
years which protected against the normal age-related decline in the subsequent five years, 
resulting in approximately normalized muscle strength.  However, other studies have 
concluded that hormone replacement theory is not effective in increasing muscle mass 
and strength in older participants (Roubenoff, 2001; Waters et al., 2000).  Due to the 
contradictory results in research, recommendations for hormone replacement 
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interventions cannot be made with regards to preventing sarcopenia (Doherty, 2003; 
Zachwieja & Yarasheski, 1999). 
Changes in estrogen concentration in women may play a role in the development of 
sarcopenia during menopause.  The decline in estrogen associated with menopause in 
women is well recognized (Messier et al., 2011).  Estrogen, as a result of its conversion to 
testosterone, has an anabolic effect on muscle. 
Altered endocrine function (Fielding et al., 2011; Nass, Johannsson, Christiansen, 
Kopchick, & Thorner, 2009), increased levels of proinflammatory cytokines (Jensen, 
2008; Roth, Metter, Ling, & Ferrucci, 2006; Schaap, Pluijm, Deeg, & Visser, 2006), 
mitochondrial dysfunction (Hiona & Leeuwenburgh, 2008; Lemasters, 2005), and 
cellular apoptosis (Kerr, Wyllie, & Curie, 1972; Marzetti & Leeuwenburgh, 2006) are 
other suggested hormonal-influenced mechanisms implicated in contributing to the 
sarcopenic loss of muscle function. 
2.3 Measuring Sarcopenia 
2.3.1 Muscle Quantity 
2.3.1.1 CSA 
Total muscle mass peaks around the age of 24 years (Lexell et al., 1988).  Some reports 
state that between the ages of 24 and 50, muscle mass declines slowly as only ~10% of 
total muscle mass is lost (Larsson, Grimby, & Karlsson, 1979).  Between 50 and 80 years 
of age, total muscle mass decreases further by ~30% (Lexell et al., 1988).  Other studies 
which assess muscle mass through CSA measurements have found that CSA decreases by 
as much as 40% between 20 and 60 years of age.  Differences in reported mass and CSA 
vary depending on technique, skeletal site, and gender (Levine et al., 2000).   
Loss of skeletal muscle mass with age has been documented by measurements using 
dual-energy X-ray absorptiometry (DEXA) and via muscle CSA quantified using three-
dimensional imaging methods such as X-ray computer tomography or MRI (Lang et al., 
2010).  DEXA has been found to underestimate muscle mass by as much as 20% (Narici 
& Maffulli, 2010; Ryan, Dobrovolny, Smith, Silver, & Macko, 2002) whereas, use of 
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MRI has grown in popularity over the past number of years because of its non-invasive 
ability to give excellent and highly accurate insight into the human body. 
When CSA of essential muscles of locomotion are evaluated, a 30% decrease in 
quadriceps CSA was found between young and elderly (Lexell et al., 1988; A. Young, 
Stokes, & Crowe, 1984).  Goodpaster et al. (2006) found CSA values of the total thigh 
muscle and quadriceps muscles are associated with knee extensor strength.  When 
measured at multiple muscle sites, CSAs are also associated with indices of functional 
capacity in the elderly, such as chair stand and leg strength measurements which have 
been shown to be strong predictors of falls (Visser et al., 2005; Visser et al., 2002).  A 
major reduction in CSA and the loss of muscle strength in old age (~81 years old) has 
also been shown in the elbow flexor and extensor muscles by Klein et al. (2001).  The 
decrease in CSA is a primary factor for the well documented decrease in contractile force 
generating potential in old age. 
2.3.1.2 CSA Composition 
Several computed tomography, MRI, and ultrasound studies have shown that in 
sarcopenia, the loss of muscle tissue is accompanied by infiltration of fat and connective 
tissue (Taaffe et al., 2009).  As a result, the net contractile muscle mass is smaller than 
that measured by a simple muscle CSA methods and mistakes in the estimation of 
contractile muscle mass are likely to be made if this noncontractile mass is not taken into 
account.  Musculoskeletal tissues are high in proton-containing molecules such as 
proteins and lipids.  Magnetic resonance imaging is an inherently powerful tool at 
depicting these tissues, and particularly useful and accurate in quantify the adipose 
components of muscles (Lang et al., 2010). 
Muscle quality in obese individuals is poor due to increased intramuscular adipose tissue 
(Villareal, Banks, Siener, Sinacore, & Klein, 2004) which contributes to muscle 
weakness, frailty, and disability (Blaum, Xue, Michelon, Semba, & Fried, 2005).  The 
accumulation of intramuscular fat and connective tissue has been shown to be inversely 
related to the level of physical activity (Kent-Braun, Ng, & Young, 2000).  However, fat 
infiltration of muscle causes increased difficulty of locomotion because of the added inert 
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mass.  Fat accumulation in the muscle has been linked with decreased muscle function 
(Goodpaster et al., 2001; Manini et al., 2007; Visser et al., 1998). 
It is also thought that excess adipose tissue disturbs the surrounding tissues through an 
increased inflammatory load (Lumeng, DeYoung, Bodzin, & Saltiel, 2007).  The increase 
in adipose tissue causes a macrophage infiltration mediated-release of pro-inflammatory 
cytokines (such as TNF-a, IL-6, IL-1) and adipokines (leptin, adiponectin, and resistin) 
from adipocytes (Neels & Olefsky, 2006).  Additionally, adipose tissue is known to 
secrete more than 50 different molecules related to inflammatory signals.  These 
inflammatory signals may contribute to accelerating muscle atrophy in elderly obese 
individuals by excessively stimulating proteolysis and possibly engaging myonuclear 
apoptosis (Jarosz & Bellar, 2009).  Fat infiltration is also a known mechanism for insulin 
resistance (Roubenoff, 2004).  Together fat infiltration and the muscle mass loss 
associated with sarcopenia result in continued losses of muscle mass, increases in insulin 
resistance, and risk of metabolic syndrome development (Reaven, 1988).  Stenholm et al. 
(2008) showed epidemiological evidence that obesity is associated with an accelerated 
functional decline and high risk of disease and mortality. 
2.3.1.3 Volume 
Muscle volume can account for 92% of the variance in joint torque and may be a more 
sensitive scaling factor of muscle strength than CSA (Fukunaga et al., 2001). 
Morse, Thom, Birch, & Narici (2005) reported muscle volume assessed using MRI in the 
triceps surae of elderly men was overall 22% smaller in the old men than the young men.  
Individually, muscle volumes were 27% smaller in the lateral gastrocnemius, 29% 
smaller in the medial gastrocnemius, and 17% smaller in the soleus.  The relative volume 
of the gastrocnemii is reduced to a greater extent than that of the soleus muscle.  
Following a 12 month resistance training program, Morse, Thom, Mian, et al. (2005) 
found muscle volume increased with activity with aging.  Prior to training, there was no 
significant difference in lateral gastrocnemius, medial gastrocnemius, and soleus muscle 
volumes between the training and control groups.  Following this training program, 
muscle volume increased 12% pre- to post-training within participants and was 17% 
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greater than age-matched controls in 70 year old men.  Volume increased by 19% in the 
lateral gastrocnemius, 15% in the medical gastrocnemius, and 11% in the soleus.  
However, the relative volume occupied by each muscle within the triceps surae did not 
change with training. 
Due to compensatory MU remodeling the higher type II fiber content of the gastrocnemii 
results in a greater susceptibility to atrophy whereas the high composition of type I fibers 
in the soleus (Enoka, 2008; Johnson, Sideri, Weightman, & Appleton, 1973) results in a 
greater likelihood of preservation with age (Dalton, McNeil, Doherty, & Rice, 2008). 
The decrease in muscle volume (along with the decrease in CSA and fiber fascicle 
length) suggests that sarcopenia involves a loss of sarcomeres not only in parallel but also 
in series (Narici & Maffulli, 2010; Narici, Maganaris, Reeves, & Capodagilo, 2003). 
2.3.2 Muscle Quality 
2.3.2.1 Normalized Strength 
Conflicting results have been reported regarding normalized strength changes with age.  
Several investigations have found significant decreases (Jubrias et al., 1997; Klein et al., 
2001; McNeil, Vandervoort, & Rice, 2007; A. Young et al., 1985), whereas others have 
not found any differences (Frontera et al., 2008; Frontera, Suh, et al., 2000; Kent-Braun 
& Ng, 1999).  Those reporting differences have found a greater reduction in strength than 
CSA and therefore reduced normalized strength. 
Klein et al. (2001) examined the normalized strength of the elbow flexors and elbows 
extensors and found a significant decline in normalized strength in both.  It is possible 
that the maintenance of normalized strength, like MUs, is dependent on use.  McNeil et 
al. (2007) compared the dorsiflexors of young, old, and very old men and found that 
isometric strength decreased in the very old men by 33% and 25% compared to young 
and old men, respectively; whereas CSA was similar among the three groups.  This 
resulted in a significant decrease in specific strength of the very old men compared to the 
young.  However, other researchers have found opposing results.  Kent-Braun & Ng 
(1999) found in the dorsiflexors, young men had a higher MVC compared with elderly 
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men, but also a decreased CSA of elderly men compared to young men.  However, there 
was no age-related impairment of specific strength.  When strength was normalized to 
volume, Morse, Thom, Mian, et al. (2005) found plantar flexion in elderly males is 
reduced compared to young males.  These opposing results make a conclusion for the 
differences difficult.  Further investigation using a combination of muscle quality 
evaluation techniques is necessary. 
2.3.2.2 MTR 
Magnetization transfer is a MRI protocol which has been used in several studies mainly 
to investigate the structural integrity of tissue in patients with various neurological and 
musculoskeletal conditions (Knight et al., 2005; Mattila et al., 1995; Schwenzer et al., 
2009; Sinclair et al., 2012; Sinclair et al., 2010; Ulmer et al., 1998; Wolff & Balaban, 
1994).   
Normal skeletal muscle is known to have strong MT interactions, presumably related to 
the high concentration of hydrophilic protein macromolecules (Boss et al., 2006; 
Yousem, Schnall, Doughtery, Weinstein, & Hayden, 1994).  It is known that MTR 
decreases are found in muscle edema (Boss et al., 2006), myonecrosis (Mattila et al., 
1995), thyroid-related ophthalmopathy (Ulmer et al., 1998), and is also induced by 
exercise (Yoshioka et al., 1994; Zhu, Zhao, & Isherwood, 1992).  Changes in MTR seem 
to depend not only on these factors but also on changes in the muscular structure itself 
(Schwenzer et al., 2009).  It is suggested that this decrease in MTR results from increased 
free water content, decrease in macromolecules, and dynamic changes of water-
macromolecule interaction in skeletal muscle (Grossman, Gomori, Ramer, Lexa, & 
Schnall, 1994; Henkelman et al., 2001).   
Schwenzer et al. (2009) found a decrease in MTR in the TA with aging when comparing 
healthy young (~31 years old) to healthy old (~66 years old) groups.  Magnetization 
transfer ratio, in this study decreased from 0.47 percentage units (p.u.) in young to 0.44 
p.u. in old. 
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2.3.2.3 Neuromuscular Measures 
Neuromuscular measures including CMAP, motor unit discharge rate (Bellemare, 
Woods, Johansson, & Bigland-Ritchie, 1983; Connelly, Rice, Roos, & Vandervoort, 
1999; Dalton, Harwood, Davidson, & Rice, 2009), neural activation (Narici, Roi, 
Landoni, Minetti, & Cerretelli, 1989) contraction duration (Vandervoort & Symons, 
2001), and MUNE (McNeil et al., 2005b; Power et al., 2010) can used to evaluate the 
neuromuscular health of muscle with aging. 
In a review by Vandervoort (2002), examples of contraction durations between young 
and old were shown to have a slowing in the lower limb from ~180ms to ~255ms 
respectively, in the dorsiflexors and from ~260ms to ~350ms, respectively, in the plantar 
flexors (Vandervoort & McComas, 1986). However, in the upper limb, contraction 
duration was consistent across age groups; ~130ms in the elbow extensors and ~139ms in 
the elbow flexors (Jakobi & Rice, 2001). 
As stated previously, MUNE, which is a calculation based on the SMUP and the CMAP, 
declines in older age groups.  In a study of the TA by McNeil et al. (2005b) young men 
were found to have ~150 MUs, old men ~91 MUs, and very old men experiencing a 
significant precipitous decline with ~59 MUs.  
Ideally, a comprehensive recording of all these factors, as well as the measures these 
factors are derived from (e.g. contraction duration is the sum of half relaxation time and 
time to peak torque), would provide the most insight into the neuromuscular adaptations 
across different age groups.  These recording would allow for a complete interpretation of 
the excitability of the muscle.  Neuromuscular excitability is influential on muscle mass 
and therefore, muscle function (Vandervoort, 1992).  
2.4 Prevalence of Sarcopenia 
In those populations over 60 years old, the prevalence of sarcopenia may be as high as 
30% and may approach 50% in those populations over 75 years old; this prevalence will 
continue to grow as the population ages (Doherty, 2003).  The strong association between 
sarcopenia and disability among the elderly populations bring to attention the need to 
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further examine the time course and causes of sarcopenia, as well as a valid way to 
measure the process and progress. 
In the United States of America, the costs associated with caring for an individual with 
sarcopenia have been linked to increased overall health care costs (Buford et al., 2010; 
Janssen, Shepard, Katzmarzyk, & Roubenoff, 2004).  The absolute costs of sarcopenia 
linked functional disability are expected to double over the next 25 years (Buford et al., 
2010). 
In the New Mexico Elder Survey, Baumgartner et al. (1998) measured muscle mass by 
DEXA, in 883 elderly men and women.  The prevalence of sarcopenia ranged from 13% 
to 24% in persons between 65 and 70 years old and was over 50% for those older than 80 
years old.  In this study, the prevalence was higher for men (58%) than for women (45%) 
over 75 years old.  Sarcopenic men and women had 3.6 and 4.1 times higher rates of 
disability, respectively, compared with those with greater muscle mass.  Another study by 
Janssen et al. (2002) found that with sarcopenia, functional impairment and disability 
were two times greater in older men and three times greater in older women. 
Iannuzzi-Sucich, Prestwood, & Kenny (2002) also used DEXA to measure appendicular 
skeletal muscle mass in women and men between the ages of 64 and 93 years old.  
Overall prevalence of sarcopenia was found to be 27% in men and 23% in women.  
However in men and women over the age of 80, these values climbed to 31% and 45%, 
respectively. 
In the next 20 years, the number of people and proportion of the population over the age 
of 65 is predicted to increase (Abellan van Kan et al., 2011).  The concurrent 
multifactorial nature of sarcopenia brings attention to the importance of intervention 
strategies that target multiple modifiable risk factors to help improve muscle function. 
2.5 Preventing Sarcopenia 
Currently, the extent to which countermeasures including exercise, nutritional, and 
pharmacological interventions are able to help retard sarcopenia, improve function, and 
decrease disability in the elderly are not well established (Hurley, Hanson, & Sheaff, 
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2011).  A few studies have examined sarcopenia prevention and generally it has been 
concluded that long-term training is necessary to prevent sarcopenia.  However, multiple, 
well-designed intervention studies, including the use of functional measures, directed 
towards elderly populations are still necessary (Doherty, 2003). 
Short-term training studies have consistently resulted in significant strength gains in 
elderly men and women (A. B. Brown, McCartney, & Sale, 1990; Charette et al., 1991; 
Frontera et al., 1988; McCartney, McKelvie, Martin, Sale, & MacDougall, 1993).  
Hakkinen et al. (1998) examined the effects of a 24-week strength training and exercise 
regime in middle aged and elderly men.  It was concluded that the adaptation to strength 
training among the elderly men was similar to that detected among the middle aged men, 
when training protocols were matched for intensity, volume, and duration. 
The extent to which life-long activity and training can prevent age-related declines in 
strength has not been thoroughly studied.  Klitgaard et al. (1990), in a cross-sectional 
study, compared elderly men who had either trained with running, swimming, or strength 
training regularly for between 12 and 17 years with young and elderly sedentary controls.  
In comparison to the young controls, they reported strength declines in the sedentary 
elderly group. 
Multiple factors must be considered when designing sarcopenia prevention studies 
including the population, training intensity, and duration of the training, and the outcome 
measured.   
As our population ages, it is clear that we require greater understanding of the underlying 
mechanisms leading to sarcopenia.  Only then can we begin to develop effective targeted 
interventions to prevent disability and optimize independence in older men and women.  
An optimal exercise program for the prevention of sarcopenia will include considerations 
such as continuous neuromuscular training, mobilization, prevention of falls, training of 
nutritional skills and improvement of nutrition, and improvement of the impaired protein 
synthesis (Muhlberg & Sieber, 2004). 
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Chapter 3  
3 Methods 
3.1 Participants 
Twelve young men (25 ± 3 years old) were recruited from the university population, and 
six old (68 ± 5 years old) and six very old (79 ± 3 years old) men were recruited from a 
local, regular exercise program designed to maintain cardiorespiratory endurance and 
flexibility.  All participants were active with no known neurological or cardiovascular 
diseases, and groups were matched approximately for height and mass.  Prior to the MRI, 
participants were given a MRI screening questionnaire to ensure safety (see Appendix 
A).  The study protocol was approved by The University of Western Ontario Research 
Ethics Board for Health Sciences Research Involving Human Subjects (see Appendix B) 
and conformed to the Declaration of Helsinki.  Informed oral and written consent was 
obtained prior to testing. 
3.2  MRI 
Magnetic resonance (MR) images were acquired via serial axial plane in a 3.0 Telsa 
magnet.  Proton density 2D FLASH images were acquired using the following 
parameters:  1500ms repetition time, 14ms echo time, 256x192 matrix, 243x325mm field 
of view, 5mm slice thickness with slice separation of 2mm.  Participants were inserted 
into the magnet bore feet first, in the supine position, with the motor point on their right 
leg [7cm distal to the tibial tuberosity and 2cm lateral to the tibial anterior border (Botter 
et al., 2011)] isocentred to the bore of the magnet and a flex coil placed over the TA.  To 
ensure minimal movement between scans, the feet and knees of participants were 
strapped together using inelastic, Velcro straps.  Four series of 30 slices each were 
obtained imaging the entire musculature of the leg from the tibial plateau to the malleoli.  
Scans with the MT presaturation, off-resonance frequency were taken in series first, 
followed by a series of scans taken without presaturation.  Presaturation scans had a 
higher specific absorption ratio and therefore any necessary adjustments made to the 
presautrated scan could be replicated for the scans without presaturation. 
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3.3 Muscle Quantity 
3.3.1 CSA, CSA Composition & Volume 
Total muscle CSAs, CSA composition, and volumes were calculated pixel-wise using a 
combination of manual and semi-automated techniques with open-source OsiriX image 
processing software (version 3.7, Geneva, Switzerland).  Muscle CSAs were calculated at 
the slice with the largest CSA.  Analysis began proximally from the first slice, in which 
the TA appeared to the most distal slice containing the TA.  A region of interest (ROI) 
was manually outlined on the most proximal slice that the TA appears in, with the brush 
tool and repeated every five slices; missing ROIs on the skipped slices were 
automatically generated.  With the TA outlined, all pixels outside the ROIs were set to 
zero.  To quantify the contractile only tissue, a three-dimensional threshold-growing tool 
was used to ensure only muscular tissue was included in the ROIs (excluding non-
contractile tissue and septal spaces).  Any errors produced by the automatic generation 
were corrected manually.  The software calculated muscle CSA and volume for the ROIs.  
Previous research has shown a high degree of intra- (ICC=0.997) and inter-rater 
reliability (ICC=0.997) with this analysis technique (Berger, 2011).  In this study, images 
were reanalyzed at random and similar retest values were found. 
3.4 Muscle Quality 
3.4.1 Normalized Strength 
To determine maximal dorsiflexion torque, participants were seated in a custom built 
isometric dynamometer with the hip and knee angles positioned at 90° and the ankle at 
30° plantar flexion.  To minimize confounding hip and knee joint movement during 
dorsiflexion contractions, an adjustable C-shaped brace was secured firmly on the distal 
portion of the thigh.  Velcro strapping across the toes and dorsum secured the foot to the 
dynamometer (Figure 1).   
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Figure 1: Isometric strength and neuromuscular properties experimental setup. 
All testing was performed on the right (dominant) leg.  Participants performed three 
MVCs, with at least 2min rest between attempts.  Participants were provided with real 
time visual feedback of their torque and verbally exhorted.  The peak torque of the three 
attempts was taken as the maximal torque for the participant.  This torque value was then 
normalized to the previously found CSA, so that normalized strength equalled MVC/CSA 
(Nm/cm
2
). 
3.4.2 MTR 
Using the acquired MR images, M0 values and M1 values (where M0 denotes images 
without off-resonance presaturation and M1 denotes images with off-resonance 
presaturation) were found for the same ROI as CSA.  Single slice analysis was found to 
be not significantly different than whole muscle volume MTR, so to make relative 
comparison to muscle CSA the same slice ROI was used for MTR and CSA. 
The interaction of macromolecular protons and free protons of a specific tissue is 
quantitatively described by the magnetization transfer ratio (Schwenzer et al., 2009; 
Sinclair et al., 2012): 
MTR = [(M0 – M1) / M0] 
Magnetization transfer ratio was calculated in percentage units (p.u.) as change from 
baseline scan. It should be noted that the MTR-derived values depend on the parameters 
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of the sequence, and the MT prepulse and cannot be compared with values from other 
studies (Schwenzer et al., 2009). 
3.4.3 Neuromuscular Properties 
Using the same setup used during the MVC, surface EMG data were collected from the 
TA using self-adhering Ag-AgCl electrodes (1.5cm x 1.0cm; Marquette Medical 
Systems, Jupiter, Florida).  The skin over the muscle was cleaned with alcohol (70% 
isopropyl alcohol solution) prior to application of the electrodes.  An active electrode was 
positioned on the proximal portion of the TA over the motor point [7cm distal to the tibial 
tuberosity and 2cm lateral to the tibial anterior border (Botter et al., 2011)], a reference 
electrode was placed over the distal tendon at the malleoli, and a ground electrode was 
placed on the patella.  Intramuscular EMG signals were recorded via a disposable 
concentric needle electrode with a recording surface of 0.03mm
2
 (Model N53153; Teca, 
Hawthorne, New York) inserted into the TA, 5-10mm proximal to the active surface 
electrode. 
Electromyography data were acquired using decomposition enhanced spike triggered 
averaging (DE-STA) software on a Neuroscan Comperio system (Neurosoft, El Paso, 
Texas).  The DE-STA and its associated algorithms have been previously described 
(Doherty & Stashuk, 2003; Stashuk, 1999; Stashuk, Doherty, & Brown, 2003). The 
surface and intramuscular EMG signals were bandpass filtered at 5Hz to 5kHz and 10Hz 
to 10kHz, respectively.  Data collection began by determining the maximum twitch 
torque and CMAP responses.  The CMAP was evoked via supramaximal stimulation of 
the common fibular nerve distal to the fibular head using a Digitimer stimulator (Model 
DS7AH, Digitimer Welwyn Garden City, Hertfordshire, UK) with a pulse width of 100µs 
and 400V.  The electrical current intensity was progressively increased until a plateau in 
CMAP amplitude was reached.  At this point, the stimulation intensity was increased 
20% to ensure complete activation of all motor axons.  During CMAP determination, the 
active electrode was repositioned to maximize the negative-peak amplitude and minimize 
negative-peak rise time. 
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Voluntary activation was assessed using the interpolated twitch technique (Belanger & 
McComas, 1981).  The amplitude of the interpolated torque evoked during the plateau of 
the MVC was compared with a single 100μs resting twitch torque evoked ~1s following 
the MVC.  Percent voluntary activation was calculated as voluntary activation (%) = [1- 
(interpolated twitch /resting twitch)] x 100. 
Following the MVCs, participants were given 5min rest to ensure no residual fatigue.  
The investigator then inserted and manipulated the concentric needle to minimize rise 
times of the negative-peak amplitudes of the first 2-3 detected motor unit potentials 
(MUPs).  Once the investigator was satisfied with the needle position, the participants 
were asked to slowly increase their dorsiflexion torque to match a target line of 25% 
MVC within 1-2s and hold the contraction steady for ~30s, during which both the 
intramuscular and surface EMG were sampled  and stored for future analysis.  This 
contraction intensity was found to be the most effective for obtaining a representative 
MUNE in the TA (McNeil, Doherty, Stashuk, & Rice, 2005a).  Participants were given at 
least 1min of rest between these contractions.  Between contractions, repositioning of the 
needle was completed by either adjusting the depth of insertion or sampling from a new 
area.  These procedures were repeated until at least 20 suitable trains of MUPs and their 
respective SMUPs were collected. 
Decomposed EMG signals were reviewed off-line to determine the acceptability of the 
needle-detected MUP trains and their corresponding SMUPs.  First, an acceptable MUP 
train required greater than 50 detected discharges which acted as triggers for spike-
triggered averaging.  Then, the MU discharge pattern was inspected visually for a 
constant rate (i.e. coefficient of variation ≤ 30%) and a physiological mean discharge 
rate.  Lastly, the interdischarge interval histogram was examined to confirm that it 
followed a Gaussian distribution.  The SMUP trains which did not meet these criteria 
were excluded from further analysis (Boe, Stashuk, & Doherty, 2004).  The SMUPs were 
inspected visually to identify a distinct waveform which was temporally linked to the 
needle potential.  The computer generated negative-peak onset and negative-peak 
amplitude markers of the acceptable SMUPs were inspected to ensure they were accurate.  
Any markers not correctly set were repositioned manually.  A computer algorithm then 
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aligned the negative onset markers for all accepted SMUPs and created a mean SMUP 
template based upon their data-point by data-point average (Doherty & Stashuk, 2003; 
Doherty, Stashuk, & Brown, 1993).  Finally, a MUNE was derived by dividing the 
negative-peak amplitude of the CMAP by the negative peak amplitude of the mean 
SMUP.  These methods have been previously used (Dalton et al., 2008; McNeil et al., 
2005b; Power et al., 2012; Power et al., 2010). 
3.5  Statistics 
All data were analyzed using SPSS software (version 18, SPSS Inc. Chicago, Illinois).  
Univariate analyses of variance (ANOVA) were performed to identify the differences 
among groups.  The level of significance was set at P < 0.05.  When a significant main 
effect was present, a Tukey HSD post hoc test was performed to identify where 
significant differences existed.  Since voluntary activation values are not normally 
distributed, a Mann-Whitney U-test was employed to test for statistical significance of 
this variable.  A power calculation was performed on the results to ensure sufficient 
power (1 – β > 0.80) was achieved.  All data are presented as mean ± SD. 
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Chapter 4  
4 Results 
4.1 Participant Characteristics 
Table 1 shows the mean values for age, height, and mass for the participants for the three 
age groups. There were no significant differences among the groups for height or mass (P 
> 0.05).  The young ranged in age from 22 to 30 years old, the old ranged in age from 60 
to 73 years old, and the very old ranged in age from 76 to 85 years old. 
Table 1: Participant characteristics. 
Group Age (years) Height (cm) Mass (kg) 
Young (n = 12) 25 ± 3 179.0 ± 5.3 82.8 ± 9.5 
Old (n = 6) 68 ± 5* 175.0 ± 3.9 95.1 ± 15.1 
Very Old (n = 6) 79 ± 3*† 174.2 ± 3.8 80.3 ± 10.8 
Values are means ± standard deviations.  *significantly different than young, †significantly 
different than old (P < 0.05). 
4.2 MR Sample Images 
Figure 2 shows representative MR images of young, old, and very old participants.  Row 
A contains images taken without off-resonance presaturation of the young, old, and very 
old men.  Row B contains images taken with off-resonance presaturation of the young, 
old, and very old men.  Sample ROIs are outlined in white.  
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Figure 2: Representative MR images of the right leg of young, old, and very old 
participants including a sample outline of a ROI in white.   
4.3 Muscle Quantity 
4.3.1 CSA, CSA Composition, & Volume 
As shown in Table 2, total CSA was not significantly different across all three groups (P 
> 0.05); however, contractile CSA was significantly lower in the very old (11.2 ± 1.0cm
2
) 
men versus the young (12.7 ± 1.6cm
2
) (P = 0.042) men, but not between the young and 
old (P = 0.129).  Absolute noncontractile CSA was higher in the very old (3.6 ± 1.8 cm
2
) 
than the young (1.8 ± 0.5cm
2
) (P = 0.010) but not the old (3.0 ± 1.1cm
2
) (P = 0.105).   
Table 2: CSA & CSA composition. 
Group 
Contractile 
(cm
2
) 
Noncontractile 
(cm
2
) 
Total CSA 
(cm
2
) 
Young 13.4 ± 1.9 1.8 ± 0.5 15.2 ± 2.2 
Old 11.7 ± 1.4 3.0 ± 1.1 14.7 ± 1.3 
Very Old 11.2 ± 1.5* 3.6 ± 1.8* 14.8 ± 1.0 
*significantly different than young (P < 0.05). 
As a percentage of total muscle CSA, the noncontractile tissue accounted for a 
significantly higher percentage in the old (20.5 ± 7.2%) (P = 0.048) and very old (24.2 ± 
10.6%) (P = 0.004) compared to the young (12.0 ± 3.3%) (Figure 3). 
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Figure 3: CSA composition as a percent of total CSA in the young, old, and very old 
men.  *significantly different than young (P < 0.05). 
Muscle volume showed a significant decrease among the three age groups (Figure 4).  
Muscle volume was ~17% lower in the old and ~19% lower in the very old men than the 
young men. 
 
Figure 4: Muscle volume in young, old, and very old men. *significantly different 
than young (P < 0.05). 
32 
 
4.4  Muscle Quality 
4.4.1 Normalized Strength 
Maximal voluntary isometric torque was ~26% lower in the old (P = 0.002) and ~24% 
lower in very old men (P = 0.005) compared to the young men (Table 3). 
Table 3: Strength and normalized strength values for the TA. 
Group 
MVC  
(Nm) 
Strength  
Normalized 
to Total CSA 
(Nm/cm
2
) 
Strength 
Normalized to 
Contractile CSA 
(Nm/cm
2
) 
Strength 
Normalized to 
Volume 
(Nm/cm
3
) 
Young 53.9 ± 7.8 3.6 ± 0.4 4.0 ± 0.4 0.23 ± 0.02 
Old 39.8 ± 6.5* 2.7 ± 0.6* 3.4 ± 0.6 0.20 ± 0.03 
Very Old 40.9 ± 6.4* 2.8 ± 0.3* 3.7 ± 0.6 0.21 ± 0.03 
*significantly different than young (P < 0.05). 
When strength was normalized to total CSA, both the old (2.8 ± 0.3Nm/cm
2
) (P = 0.002) 
and very old (2.7 ± 0.6Nm/cm
2
) (P = 0.003) men showed significantly lower normalized 
strength than the young men (3.6 ± 0.4Nm/cm
2
) (Figure 5 – hatched bars). 
 
Figure 5: Strength normalized to total CSA and muscle CSA. *significantly different 
than young (P < 0.05). 
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However, when strength was normalized to only contractile CSA, the differences were no 
longer present between the young (4.0 ± 0.4Nm/cm
2
), old (3.4 ± 0.6Nm/cm
2
), and very 
old (3.7 ± 0.6 Nm/cm
2
) (P > 0.05) (Figure 5 – solid bars). 
Similarly to CSA, although significant differences existed among the groups in volume 
measures when strength was normalized to volume, no significant difference existed 
between the young (0.23 ± 0.02Nm/cm
3
), old (0.20 ± 0.03Nm/cm
3
), and very old (0.21 ± 
0.03Nm/cm
3
) (P > 0.05) (Figure 6).  This is due to a concurrent decrease of strength and 
CSA or strength and volume. 
 
Figure 6: Absolute muscle volume to strength normalized to volume.  *significantly 
different volume than young (P < 0.05). 
4.4.2 MTR 
 As shown in Figure 7, MTRs were significantly greater between the young (0.262 ± 
0.01p.u.) and very old (0.242 ± 0.02p.u.) (P = 0.049) as well as the old (0.266 ± 0.01p.u.) 
and very old (P = 0.036) but not significantly different between the young and old (P = 
0.844). 
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Figure 7: Magnetization transfer ratios young, old, and very old men. *significantly 
different than young, †significantly different than old (P < 0.05). 
4.4.3 Neuromuscular Properties 
Although there was no significant differences among groups for twitch torque (P > 0.05); 
time-to-peak torque and half relaxation times were significantly longer  in the old [24.6% 
(P = 0.015) and 26.9% (P < 0.001), respectively] and very old [30.7% (P = 0.003) and 
29.1% (P < 0.001), respectively] men compared to the young men.  As a consequence, 
contraction duration (time-to-peak torque + half relaxation time) was ~26% longer in the 
old men and ~30% longer in the very old men.  Voluntary activation, as assessed by the 
interpolated twitch technique, was near maximal (>94%) in all three groups during 
MVCs (Table 4). 
Table 4: Neuromuscular properties of the TA. 
Group VA (%) Pt (Nm) TPT (ms) HRT (ms) CD (ms) 
Young  96.2 ± 2.4 6.6 ± 2.2 78.5 ± 14.5 94.2 ± 8.5 172.7 ± 19.1 
Old 95.8 ± 2.1 5.8 ± 1.3 97.8 ± 12.9* 119.5 ± 10.8* 217.3 ± 10.9* 
Very Old 94.6 ± 1.9 6.2 ± 1.4 102.6 ± 5.7* 121.6 ± 13.7* 223.7 ± 15.0* 
MVC = absolute maximal isometric contraction torque, VA = voluntary activation, Pt = twitch torque, 
TPT = time-to-peak tension, HRT = half-relaxation time, CD = contraction duration.  Values are 
means ± standard deviations.  * significantly different than young (P < 0.05). 
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The maximum negative-peak amplitude of the CMAP was not significantly different 
between the young (6.8 ± 1.1mV), old (5.6 ± 1.4mV), and very old (5.5 ± 1.0mV) men (P 
> 0.05) (Figure 8A).  The negative-peak amplitude of the mean SMUP was only 
significantly higher in the very old men (72.8 ± 22.8μV) compared to the young (47.5 ± 
8.3μV) (P = 0.015) men.  The SMUP of the old men (54.3 ± 21.5μV) was not 
significantly different from the young or very old men (P > 0.05) (Figure 8B).   
 
 
Figure 8: Compound muscle action potentials (A) and surface motor unit potentials 
(B) of the young, old, and very old men. *significantly different than old (P < 0.05). 
36 
 
A decrease in mean CMAPs with not significantly different SMUPs in the old men 
resulted in significantly lower MUNE compared to the young men (P = 0.033).  The 
combination of a smaller mean CMAP with significantly lower SMUP of the very old 
men resulted in significantly lower MUNE than both the young (P < 0.001) and old (P = 
0.03) men.  It was estimated that the young men had 146 ± 31 MUs, the old men had 109 
± 25 MUs, and the very old men had 80 ± 21 MUs (Figure 9). 
 
Figure 9: Motor unit number estimates for young, old, and very old men. 
*significantly different than young (P < 0.05). 
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Chapter 5  
5 Discussion 
The multidimensional nature of sarcopenia highlights the importance of examining both 
quantitative and qualitative changes occurring in the muscles with aging.  The 
progression of sarcopenia is a gradual process marked by a loss of neuromuscular 
function up to the sixth and seventh decade of life.  Following this, in the eighth decade 
of life and beyond, there is a precipitous loss of muscle mass and function (Berger & 
Doherty, 2010).  Our results suggest that muscle mass is maintained in the old, likely due 
to collateral reinnervation, whereas a slowing of contractile properties becomes evident 
suggesting other intrinsic factors are affecting sarcopenia.  The subsequent precipitous 
decline of muscular function in very old men is at least partly due to MU death and 
structural integrity decreases.  With very old age, MU death out paces remodeling 
resulting in muscle fiber atrophy, and muscle quality decreases, leading to an accelerated 
loss of muscular function.  We confirmed this via a combination of CSA, volume, 
normalized strength, a novel MRI technique (MTR), and 
electrophysiological/neuromuscular measures across three age categories of men.  This 
combination of MRI and neuromuscular measures gave us exciting new insights into the 
progression of sarcopenia.  However, it is important to note that in accordance with this 
study and previous research, sarcopenia cannot be explained by a single process but is 
caused by a number of contributing factors that converge to accelerate a gradual decrease 
into a rapid decline in muscular function. 
Although total CSA was not different among the three groups, muscle atrophy did occur 
in the very old men.  In the very old men, contractile tissue decreased and noncontractile 
increased.  Decreased contractile CSA has been shown to be related to the strength 
deficits and functional limitations of sarcopenia (Newman et al., 2003; Visser et al., 
2005).  Contractile CSA is the more appropriate measure than total CSA for evaluating 
muscle quality through normalized strength.  It could be speculated the quality of the 
contractile tissue (force per unit of muscle) is maintained in the old and very old.  
Therefore, the contractile tissue of the old and very old men is still capable of performing 
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similarly to the young men.  These findings are similar to what Kent-Braun & Ng (1999) 
found for CSA using MR images of the TA in men with aging.  With age, as muscle 
fibers are abandoned, muscle mass is lost and noncontractile tissue infiltrates the muscle.  
However, the remaining muscle in the old and very old appears to have similar 
contractile torque properties as young counterparts.  Although absolute strength was 
lower in the old and very old, when this strength was normalized to muscle quantity the 
differences no longer existed.  This coincides with previous research which found that the 
contractile properties of single muscle fibers are preserved with aging (Frontera et al., 
2008; Frontera, Suh, et al., 2000).  In contrast, previously McNeil et al. (2007) found a 
decrease in normalized strength in a very old age group of men.  In that study, the very 
old men were found to have a decrease MVC, but not significantly different CSA which 
accounted for the difference in normalized strength.  In the current study, the very old 
men had a concurrent loss of strength and muscle mass resulting in no differences in 
normalized strength.  The very old group in the study by McNeil et al. (2007) was in the 
ninth decade of life, which may account for the differences.  Muscle contractile force as a 
reflection of muscle quality may be more affected than CSA in the ninth decade of life. 
The functional effects of the muscular structure decline may not become apparent until 
later in the aging process (Sinclair et al., 2012).  Magnetization transfer ratios may be a 
more sensitive measure of muscle quality and the functional declines to follow, as MTR 
depicts a decrease in muscle quality in the eighth decade of life, but normalized strength 
does not depict a decrease in muscle quality until the ninth decade of life (McNeil et al., 
2007).  Although the current study was cross-sectional in design, Figure 10 is a depictive 
possible outline of the progression of sarcopenia showing that first MUNE declines, 
followed by MTR then normalized strength.   
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Figure 10: Predictive timeline of sarcopenia.  MTR declines may precede 
normalized strength declines. 
Magnetization transfer ratio has previously been used to measure muscular structure and 
therefore, muscle quality.  Sinclair et al. (2012) found a significant decrease of MTR in 
lower limb muscle of clinical neuropathy patients.  In the middle-aged neuropathy 
patients, ~17% lower MTR values were found compared to young.  Magnetization 
transfer ratio is reflective of muscle quality in neuropathic cases, and therefore also a 
useful measure of muscle quality in healthy cases.  In support, Schwenzer et al. (2009) 
found ~6% lower MTR values for healthy old versus young participants. Including a 
group in the eighth decade of life is a novel and worthwhile approach to examining 
muscle quality using MTR.  Similarly, MTR in this study were ~8% lower in the very old 
than the young and old groups. 
In this study, MUNE results were similar to previous research on the TA with aging in 
young, old, and very old men by McNeil et al (2005b).  An age difference of 45 years 
between the young and old group showed a decrease of ~25% in mean MUNE, whereas 
in the 20 years difference between the old and very old groups, another ~27% decrease in 
mean MUNE was shown.   The compensatory strategy of collateral reinnervation 
maintains most of the muscle mass from atrophy by dying MUs.  Intact MUs sprout axon 
branches and acquire any orphaned muscle fibers resulting in larger MUs (increasing the 
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SMUP) with slower contractile speeds (TPT + HRT) due to tendency of Type II fibers to 
die first (Morley et al., 2001) and Type I MUs to innervate those fibers giving them Type 
I fiber properties.  Without this compensatory mechanism, there would be a much greater 
loss of muscle mass.  With continued aging, this compensatory strategy cannot keep up 
with motor neuron death, as demonstrated by the negative-peak amplitude of the SMUP 
being significantly higher in only the very old men.  When MUs with a greater number of 
muscle fibers die (decreased MUNE), a larger amount of excitable muscle mass 
(decreased CMAP and CSA) is lost, resulting in further reduced mass and strength.   
Together, the results from the current study suggest that both muscle quantity and muscle 
quality are declining with age.  In the old men, MTR was maintained due to the ability of 
the compensatory mechanisms of MU remodelling maintaining muscle mass and 
function.  In the very old men, MTR declined due to the inability of the compensatory 
mechanisms of MU remodeling to maintain muscle mass as a precursor to a decline in 
muscle function (Figure 11).   
 
Figure 11: Percent changes from young compared to old and very old men in the 
measures of muscle quality.  *significantly different than young (P < 0.05). 
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5.1 Summary 
In response to the research questions posed at the beginning of the study, the following 
conclusions were made:  
1. How does muscle quantity, including CSA, CSA composition, and muscle 
volume differ between young, old, and very old populations of men?  Muscle 
quantity was decreased between the young, old, and very old men.  Although total 
CSA was not significantly different between the three groups, the very old men 
had a significantly lower muscle CSA than both the young and old men.  This 
coincided with an increase in noncontractile tissue CSA in the very old men.  
Muscle volume was significantly lower in both the old and very old men 
compared to the young men. 
2. How does muscle quality, such as normalized strength, MTR, and 
neuromuscular measures differ between young, old, and very old populations 
of men?  Muscle quality results varied among the age groups depending on the 
evaluation method.  Normalized strength did not decline among any of the three 
groups (Figure 4). Magnetization transfer ratios were only significantly lower in 
the very old men. Neuromuscular properties, in particular MUNE, showed 
significant decreases between the young and both the old and very old men. 
3. Is there an ideal measure of muscle quality that reflects muscle function?  
Normalized strength, MTR, and neuromuscular techniques of evaluating muscle 
quality each have their advantages and disadvantages.  Normalized strength gives 
insight into the contractile properties of the muscles, but not the functional 
declines; MTR may be a sensitive and early detector of muscle quality changes, 
but does not reflect current functional properties; MUNE is able to demonstrate 
that MU remodeling occurs, but it is not able to show the amount of muscle mass 
lost.  
4. Does muscle quantity affect muscle quality or does muscle quality affect 
muscle quantity?  The causality dilemma of whether muscle quality affects 
42 
 
muscle quantity or whether muscle quality affects muscle quantity cannot be 
definitively answered.  Muscle quantity affects muscle quality and muscle quality 
affects muscle quantity; it is an intricate interrelated relationship.  Mechanisms 
that maintain muscle quantity also preserve muscle quality. 
5.2 Conclusions 
In conclusion, sarcopenia has two stages of progression: a gradual decline in muscle 
function in an old population, followed by an accelerated decline in muscle function in a 
very old population.  During the gradual decline, muscle volume is less in the old than the 
young.  Motor unit number estimates are less in the old than the young, but normalized 
strength and MTR are not different among the groups.  Around the eighth decade of life, 
the previously gradual decline in muscle function accelerates.  In this accelerated decline, 
contractile CSA and muscle volume are decreased in the young versus very old. Motor 
unit number estimates are lower in the very old than the young.  Although normalized 
strength has yet to experience a decline, MTRs are significantly lower in the very old 
than both the young and old.    
5.3 Strengths of the Study 
A strength of this study was the use of MRI to analyze CSA and muscle volume.  This 
non-invasive tool is very accurate and allows for the exclusion of noncontractile tissue.   
Studies on human aging which compare only two groups, young and old, do not provide 
insight on the degree or rate of change of sarcopenia especially in the later years (i.e. >70 
years old) in which faster declines are typically experienced.  Another strength of this 
study is the implementation of a third very old group of men. 
Using a muscle such as the TA was an appropriate model for examining MUNE and 
MTR for both qualitative and quantitative reasons.  Qualitatively, participants were more 
comfortable having just their legs in the MR scanner. The TA is an accessible muscle for 
performing the MUNE technique, due to the accessibility of the fibular nerve, and unlike 
the soleus, the lesser volume eliminates conduction issues allowing for reliable CMAPs.  
Quantitatively, the TA is a high use, high impact muscle during activities such as 
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walking, which was the majority of activity for participants. Previous reports have been 
made on the TA for normalized strength (Kent-Braun & Ng, 1999; McNeil et al., 2007), 
MUNE (Boe, Dalton, Harwood, Doherty, & Rice, 2009; McNeil et al., 2005b), and MTR 
(Schwenzer et al., 2009).  Typically, the muscle fiber composition of the TA is more 
Type I fibers than Type II (Enoka, 2008).  This is an advantage because Type II muscle 
fiber appear to selectively die first (Morley et al., 2001), so MU death with aging would 
be shown earlier in muscles with this type of composition.  Additionally, muscle 
composed of an even higher percentage Type I fibers, such as the soleus, have been 
shown to maintain a large majority of MUs with age (Dalton et al., 2008). 
The comprehensive combination of evaluations which include measurements of both 
muscle quantity and muscle quality is a major strength of this study.  Having 
physiological, morphological, and neuromuscular measures allow for an in depth and 
more comprehensive evaluation of the muscle properties and the development of 
sarcopenia.  
5.4 Limitations of the Study 
Limitations of this study are a small samples size in the old and very old groups, the lack 
of muscle biopsies, and histochemical analysis.  Muscle biopsies would complement and 
confirm inferences made on the fiber type composition changes from type II to 
predominately type I.  Histochemical analysis would have allowed for observations of the 
hormonal changes affecting the old men with sarcopenia. 
Longitudinal aging studies are difficult to complete, so this study has employed a cross-
sectional study design.  Cross-sectional studies, however, do not allow for detail into the 
progression of sarcopenia along a continuous timeline but instead, a glimpse into several 
stages of aging.  Another limitation of a cross-sectional design is in the selection of 
participants.  Cross-sectional studies underestimate age-related change in muscle function 
(Frontera, Hughes, et al., 2000) and represent a comparison only with those that have 
survived advanced age.  Persons with stronger muscles may have a better chance of being 
included in cross-sectional studies because they have survived to old age (Frontera et al., 
2008). 
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5.5 Future Directions 
Future studies should address the muscle biopsy and histochemical limitations and further 
examine muscle changes with dynamic contractions, force steadiness, and balance.  
Dynamic measures such as contraction velocity and power would give valuable 
information about the contractile and functional properties of the muscle.  Force 
steadiness and balance are both functional measures that could be matched to the muscle 
measures to validate conclusions about the effects of changing muscle on function with 
aging.  Loss of muscular strength is more subtle in eccentric testing conditions 
(Hortobagyi et al., 1995; Vandervoort, Kramer, & Wharram, 1990) and therefore, when 
examining the dynamic properties of the muscle both concentric and eccentric testing 
conditions should be compared.   
Other MR techniques such as short tau inversion recovery imaging and T2 weighted 
images (Kamath, Venkatanarasimha, Walsh, Hughes, 2008; Sinclair et al., 2012) can be 
used to look at the denervation within the muscle and be correlated with MUNE.  
Ultrasound to determine fascicle length and angle of pennation would also be a 
potentially useful technique to combine with these other measures.  Muscle strength is 
dependent on fascicle length and angle of pennation by which the tendon inserts into the 
muscle, both of which may alter with age (Binzoni et al., 2001; Narici, Maffulli, & 
Maganaris, 2008). 
It is unknown whether our results are selective to the TA or whether a similar pattern is 
followed in other muscles.  Muscle composition of type I and type II fibers varies among 
muscles depending on the requirements and function of the muscle.  Examining several 
muscles with various muscle compositions would also be important when examining 
sarcopenia (Vella & Kravitz, 2002).   
In order to continue furthering our insights into sarcopenia, we must also examine all 
these measures across several different populations.  Continuing this study by including a 
middle-aged group and an older population of men in the ninth and tenth decades of life 
would give insight into the continued progress of sarcopenia, following the precipitous 
decline experienced beyond the eighth decade of life.  Considering all of these measures 
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in groups of women would be a valuable next step in sarcopenia research, as women may 
experience sarcopenia differently than men.  Examining sex differences may bring further 
understanding of sarcopenia and may help devise inclusive prevention techniques.  
Clinical populations would also be useful to compare healthy aging muscle to diseased 
aging muscle. 
Although longitudinal studies in humans from adult to old age are challenging to 
accomplish, a longitudinal study would give a higher degree of specificity of age-related 
changes, especially during the years of faster declines. 
With a thorough understanding, a valid and reliable standardized definition and clinical 
evaluation, that includes severity and preventions, can be created (Abellan van Kan et al., 
2011; Pahor, Manini, & Cesari, 2009) for sarcopenia.   
 
46 
 
References 
Abellan Van Kan, G., Cedarbaum, J., Cesari, M., Dahinden, P., Fariello, R., Fielding, R., 
. . . Vellas, B. (2011). Sarcopenia: Biomarkers and imaging (International 
Conference on Sarcopenia research). Journal of Nutrition, Health & Aging, 
15(10), 834-846. doi: 10.1007/s12603-011-0365-1 
Anthony, J. C., Reiter, A. K., Anthony, T. G., Crozier, S. J., Lang, C. H., MacLean, D. 
A., . . . Jefferson, L. S. (2002). Orally administered leucine enhances protein 
synthesis in skeletal muscle of diabetic rats in the absence of increases in 4E-BP1 
or S6K1 phosphorylation. Diabetes, 51(4), 928-936. doi: 
10.2337/diabetes.51.4.928 
Balagopal, P., Rooyackers, O. E., Adey, D. B., Ades, P. A., & Nair, K. S. (1997). Effects 
of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and 
sarcoplasmic protein in humans. American Journal of Physiology - Endocrinology 
and Metabolism, 273(4), E790-E800.  
Bales, C. W., & Ritchie, C. S. (2002). Sarcopenia, weight loss, and nutritional fraility in 
the elderly. Annual Review of Nutrition, 22(1), 309-323. doi: 
doi:10.1146/annurev.nutr.22.010402.102715 
Baudry, S., Klass, M., & Duchateau, J. (2005). Postactivation potentiation influences 
differently the nonlinear summation of contractions in young and elderly adults. 
Journal of Applied Physiology, 98(4), 1243-1250. doi: 
10.1152/japplphysiol.00735.2004 
Bauer, J. M., Kaiser, M. J., & Sieber, C. C. (2008). Sarcopenia in nursing home residents. 
Journal of the American Medical Directors Association, 9(8), 545-551. doi: 
10.1016/j.jamda.2008.04.010 
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, 
R. R., . . . Lindeman, R. D. (1998). Epidemiology of sarcopenia among the elderly 
in New Mexico. American Journal of Epidemiology, 147(8), 755-763.  
47 
 
Baumgartner, R. N., Waters, D. L., Gallagher, D., Morley, J. E., & Garry, P. J. (1999). 
Predictors of skeletal muscle mass in elderly men and women. Mechanisms of 
Ageing and Development, 107(2), 123-136. doi: 10.1016/s0047-6374(98)00130-4 
Belanger, A. Y., & McComas, A. J. (1981). Extent of motor unit activation during effort. 
Journal of Applied Physiology, 51(5), 1131-1135.  
Bellemare, F., Woods, J. J., Johansson, R., & Bigland-Ritchie, B. (1983). Motor-unit 
discharge rates in maximal voluntary contractions of three human muscles. 
Journal of Neurophysiology, 50(6), 1380-1392.  
Berger, M. (2011). Characterization of quadriceps neuromuscular function in knee 
osteoarthritis., The University of Western Ontario, London, Ontario, Canada.    
Berger, M., & Doherty, T. (2010). Sarcopenia: Prevalence, mechanisms, and functional 
consequences. Interdisciplinary Topics in Gerontology, 37, 94-114.  
Binzoni, T., Bianchi, S., Hanquinet, S., Kaelin, A., Sayegh, Y., Dumont, M., . . . quier, S. 
(2001). Human gastrocnemius medialis Pennation Angle as a Function of Age: 
From Newborn to the Elderly. Journal of Physiological Anthropology and 
Applied Human Science, 20(5), 293-298.  
Blaum, C. S., Xue, Q. L., Michelon, E., Semba, R. D., & Fried, L. P. (2005). The 
association between obesity and the frailty syndrome in older women: The 
women's health and aging studies. Journal of the American Geriatrics Society, 
53(6), 927-934. doi: 10.1111/j.1532-5415.2005.53300.x 
Bloomer, R. J., Goldfarb, A. H., Wideman, L., McKenzie, M. J., & Consitt, L. A. (2005). 
Effects of acute aerobic and anaerobic exercise on blood markers of oxidative 
stress. Journal of Strength and Conditioning Research, 19(2), 276-285.  
Boe, S. G., Dalton, B. H., Harwood, B., Doherty, T. J., & Rice, C. L. (2009). Inter-rater 
reliability of motor unit number estimates and quantitative motor unit analysis in 
the tibialis anterior muscle. Clinical Neurophysiology, 120(5), 947-952. doi: 
10.1016/j.clinph.2009.02.168 
48 
 
Boe, S. G., Stashuk, D. W., & Doherty, T. J. (2004). Motor unit number estimation by 
decomposition-enhanced spike-triggered averaging: Control data, test–retest 
reliability, and contractile level effects. Muscle & Nerve, 29(5), 693-699. doi: 
10.1002/mus.20031 
Boss, A., Martirosian, P., Küper, K., Fierlbeck, G., Claussen, C. D., & Schick, F. (2006). 
Whole-body magnetization transfer contrast imaging. Journal of Magnetic 
Resonance Imaging, 24(5), 1183-1187. doi: 10.1002/jmri.20754 
Botter, A., Oprandi, G., Lanfranco, F., Allasia, S., Maffiuletti, N., & Minetto, M. (2011). 
Atlas of the muscle motor points for the lower limb: implications for electrical 
stimulation procedures and electrode positioning. European Journal of Applied 
Physiology, 111(10), 2461-2471. doi: 10.1007/s00421-011-2093-y 
Boumendjel, N., Herrmann, F., Girod, V., Sieber, C., & Rapin, C.-H. (2000). Refrigerator 
content and hospital admission in old people. The Lancet, 356(9229), 563. doi: 
10.1016/s0140-6736(00)02583-6 
Boyle, J. P., Honeycutt, A. A., Narayan, K. M. V., Hoerger, T. J., Geiss, L. S., Chen, H., 
& Thompson, T. J. (2001). Projection of diabetes burden through 2050. Diabetes 
Care, 24(11), 1936-1940. doi: 10.2337/diacare.24.11.1936 
Bromberg, M. B. (2007). Updating motor unit number estimation (MUNE). Clinical 
Neurophysiology, 118(1), 1-8. doi: 10.1016/j.clinph.2006.07.304 
Brown, A. B., McCartney, N., & Sale, D. G. (1990). Positive adaptations to weight-lifting 
training in the elderly. Journal of Applied Physiology, 69(5), 1725-1733.  
Brown, W. F. (1972). A method for estimating the number of motor units in thenar 
muscles and the changes in motor unit count with ageing. Journal of Neurology, 
Neurosurgery & Psychiatry, 35(6), 845-852. doi: 10.1136/jnnp.35.6.845 
Brown, W. F., Strong, M. J., & Snow, R. (1988). Methods for estimating numbers of 
motor units in biceps-brachialis muscles and losses of motor units with aging. 
Muscle & Nerve, 11(5), 423-432. doi: 10.1002/mus.880110503 
49 
 
Buford, T. W., Anton, S. D., Judge, A. R., Marzetti, E., Wohlgemuth, S. E., Carter, C. S., 
. . . Manini, T. M. (2010). Models of accelerated sarcopenia: Critical pieces for 
solving the puzzle of age-related muscle atrophy. Ageing Research Reviews, 9(4), 
369-383. doi: 10.1016/j.arr.2010.04.004 
Burke, R. E., Levine, D. N., Tsairis, P., & Zajac, F. E. (1973). Physiological types and 
histochemical profiles in motor units of the cat gastrocnemius. Journal of 
Physiology, 234(3), 723-748.  
Campbell, M. J., McComas, A. J., & Petito, F. (1973). Physiological changes in ageing 
muscles. Journal of Neurology, Neurosurgery & Psychiatry, 36(2), 174-182. doi: 
10.1136/jnnp.36.2.174 
Candow, D. G., & Chilibeck, P. D. (2005). Differences in size, strength, and power of 
upper and lower body muscle groups in young and older men. The Journals of 
Gerontology Series A: Biological Sciences and Medical Sciences, 60(2), 148-156. 
doi: 10.1093/gerona/60.2.148 
Castaneda, C., Charnley, J., Evans, W., & Crim, M. (1995). Elderly women 
accommodate to a low-protein diet with losses of body cell mass, muscle 
function, and immune response. The American Journal of Clinical Nutrition, 
62(1), 30-39.  
Cefalu, W. T., Wang, Z. Q., Werbel, S., Bell-Farrow, A., Crouse Iii, J. R., Hinson, W. H., 
. . . Anderson, R. (1995). Contribution of visceral fat mass to the insulin resistance 
of aging. Metabolism, 44(7), 954-959. doi: 10.1016/0026-0495(95)90251-1 
Cesari, M., Ferrini, A., Zamboni, V., & Pahor, M. (2008). Sarcopenia: Current clinical 
and research issues. The Open Geriatric Medicine Journal, 1(1), 14-23.  
Cesari, M., Kritchevsky, S. B., Baumgartner, R. N., Atkinson, H. H., Penninx, B. W., 
Lenchik, L., . . . Pahor, M. (2005). Sarcopenia, obesity, and inflammation results 
from the Trial of Angiotensin Converting Enzyme Inhibition and Novel 
50 
 
Cardiovascular Risk Factors study. American Journal of Clinical Nutrition, 82(2), 
428-434.  
Charette, S. L., McEvoy, L., Pyka, G., Snow-Harter, C., Guido, D., Wiswell, R. A., & 
Marcus, R. (1991). Muscle hypertrophy response to resistance training in older 
women. Journal of Applied Physiology, 70(5), 1912-1916.  
Chomentowski, P., Dubé, J. J., Amati, F., Stefanovic-Racic, M., Zhu, S., Toledo, F. G. S., 
& Goodpaster, B. H. (2009). Moderate exercise attenuates the loss of skeletal 
muscle mass that occurs with intentional caloric restriction–induced weight loss in 
older, overweight to obese adults. The Journals of Gerontology Series A: 
Biological Sciences and Medical Sciences, 64A(5), 575-580. doi: 
10.1093/gerona/glp007 
Coin, A., Sergi, G., Benincà, P., Lupoli, L., Cinti, G., Ferrara, L., . . . Enzi, G. (2000). 
Bone mineral density and body composition in underweight and normal elderly 
subjects. Osteoporosis International, 11(12), 1043-1050. doi: 
10.1007/s001980070026 
Combaret, L., Dardevet, D., Béchet, D., Taillandier, D., Mosoni, L., & Attaix, D. (2009). 
Skeletal muscle proteolysis in aging. Current Opinion in Clinical Nutrition & 
Metabolic Care, 12(1), 37-41 10.1097/MCO.1090b1013e32831b32839c32831.  
Connelly, D. M., Rice, C. L., Roos, M. R., & Vandervoort, A. A. (1999). Motor unit 
firing rates and contractile properties in tibialis anterior of young and old men. 
Journal of Applied Physiology, 87(2), 843-852.  
Dalton, B. H., Harwood, B., Davidson, A. W., & Rice, C. L. (2009). Triceps surae 
contractile properties and firing rates in the soleus of young and old men. Journal 
of Applied Physiology, 107(6), 1781-1788. doi: 10.1152/japplphysiol.00464.2009 
Dalton, B. H., McNeil, C. J., Doherty, T. J., & Rice, C. L. (2008). Age-related reductions 
in the estimated numbers of motor units are minimal in the human soleus. Muscle 
& Nerve, 38(3), 1108-1115. doi: 10.1002/mus.20984 
51 
 
de Koning, P., Wieneke, G. H., van der Most van Spijk, D., van Huffelen, A. C., Gispen, 
W. H., & Jennekens, F. G. (1988). Estimation of the number of motor units based 
on macro-EMG. Journal of Neurology, Neurosurgery & Psychiatry, 51(3), 403-
411. doi: 10.1136/jnnp.51.3.403 
De Luca, C. J., & Hostage, E. C. (2010). Relationship between firing rate and recruitment 
threshold of motoneurons in voluntary isometric contractions. Journal of 
Neurophysiology, 104(2), 1034-1046. doi: 10.1152/jn.01018.2009 
DeSouza, C. A., Shapiro, L. F., Clevenger, C. M., Dinenno, F. A., Monahan, K. D., 
Tanaka, H., & Seals, D. R. (2000). Regular aerobic exercise prevents and restores 
age-related declines in endothelium-dependent vasodilation in healthy men. 
Circulation, 102(12), 1351-1357. doi: 10.1161/01.cir.102.12.1351 
Dillon, E. L., Sheffield-Moore, M., Paddon-Jones, D., Gilkison, C., Sanford, A. P., 
Casperson, S. L., . . . Urban, R. J. (2009). Amino acid supplementation increases 
lean body mass, basal muscle protein synthesis, and insulin-like growth factor-1 
expression in older women. Journal of Clinical Endocrinology & Metabolism, 
94(5), 1630-1637. doi: 10.1210/jc.2008-1564 
Doherty, T. J. (2003). Invited Review: Aging and sarcopenia. Journal of Applied 
Physiology, 95(4), 1717-1727. doi: 10.1152/japplphysiol.00347.2003 
Doherty, T. J., & Brown, W. F. (1993). The estimated numbers and relative sizes of 
thenar motor units as selected by multiple point stimulation in young and older 
adults. Muscle & Nerve, 16(4), 355-366. doi: 10.1002/mus.880160404 
Doherty, T. J., & Brown, W. F. (1997). Age-related changes in the twitch contractile 
properties of human thenar motor units. Journal of Applied Physiology, 82(1), 93-
101.  
Doherty, T. J., & Brown, W. F. (2002). Motor unit number estimation: methods and 
applications. In W. F. Brown, C. F. Bolton & M. J. Aminoff (Eds.), 
52 
 
Neuromuscular Function and Disease: Basic, Clinical, and Electrodiagnosis 
Aspects (pp. 274-290). Philadelphia, PA: Saunders. 
Doherty, T. J., Simmons, Z., O'Connell, B., Felice, K. J., Conwit, R., Chan, K. M., . . . 
Brown, W. F. (1995). Methods for estimating the numbers of motor units in 
human muscles. Journal of Clinical Neurophysiology: Official Publication of the 
American Electroencephalographic Society, 12(6), 565-584.  
Doherty, T. J., & Stashuk, D. W. (2003). Decomposition-based quantitative 
electromyography: Methods and initial normative data in five muscles. Muscle & 
Nerve, 28(2), 204-211. doi: 10.1002/mus.10427 
Doherty, T. J., Stashuk, D. W., & Brown, W. F. (1993). Determinants of mean motor unit 
size: Impact on estimates of motor unit number. Muscle & Nerve, 16(12), 1326-
1331. doi: 10.1002/mus.880161209 
Doherty, T. J., Vandervoort, A. A., & Brown, W. F. (1993). Effects of ageing on the 
motor unit: A brief review. Canadian Journal of Applied Physiology, 18(4), 331-
358. doi: 10.1139/h93-029 
Doherty, T. J., Vandervoort, A. A., Taylor, A. W., & Brown, W. F. (1993). Effects of 
motor unit losses on strength in older men and women. Journal of Applied 
Physiology, 74(2), 868-874.  
Duclos, M., Corcuff, J., Pehourcq, F., & Tabarin, A. (2001). Decreased pituitary 
sensitivity to glucocorticoids in endurance-trained men. European Journal of 
Endocrinology, 144(4), 363-368. doi: 10.1530/eje.0.1440363 
Enoka, R. M. (2008). Neuromechanics of human movement: Human Kinetics. 
Evans, W. J. (1997). Functional and metabolic consequences of sarcopenia. Journal of 
Nutrition, 127(5), 998S-1003S.  
Evans, W. J. (2002). Effects of exercise on senescent muscle. Clinical Orthopaedics and 
Related Research, 403, S211-S220.  
53 
 
Evans, W. J., & Coggan, A. R. (1995). Muscle biopsy as a tool in the study of aging. The 
Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 
50A(Special Issue), 30-34. doi: 10.1093/gerona/50A.Special_Issue.30 
Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., . . . Anker, 
S. D. (2008). Cachexia: A new definition. Clinical Nutrition, 27(6), 793-799. doi: 
10.1016/j.clnu.2008.06.013 
Fiatarone, M. A., O'Neill, E. F., Ryan, N. D., Clements, K. M., Solares, G. R., Nelson, M. 
E., . . . Evans, W. J. (1994). Exercise training and nutritional supplementation for 
physical frailty in very elderly people. New England Journal of Medicine, 
330(25), 1769-1775. doi: doi:10.1056/NEJM199406233302501 
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., . . . 
Zamboni, M. (2011). Sarcopenia: An undiagnosed condition in older adults. 
Current consensus definition: Prevalence, etiology, and consequences. 
International working group on sarcopenia. Journal of the American Medical 
Directors Association, 12(4), 249-256. doi: 10.1016/j.jamda.2011.01.003 
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., . . . 
McBurnie, M. A. (2001). Frailty in older adults. The Journals of Gerontology 
Series A: Biological Sciences and Medical Sciences, 56(3), M146-M157. doi: 
10.1093/gerona/56.3.M146 
Frontera, W. R., Hughes, V. A., Fielding, R. A., Fiatarone, M. A., Evans, W. J., & 
Roubenoff, R. (2000). Aging of skeletal muscle: a 12-yr longitudinal study. 
Journal of Applied Physiology, 88(4), 1321-1326.  
Frontera, W. R., Meredith, C. N., O'Reilly, K. P., Knuttgen, H. G., & Evans, W. J. 
(1988). Strength conditioning in older men: skeletal muscle hypertrophy and 
improved function. Journal of Applied Physiology, 64(3), 1038-1044.  
Frontera, W. R., Reid, K. F., Phillips, E. M., Krivickas, L. S., Hughes, V. A., Roubenoff, 
R., & Fielding, R. A. (2008). Muscle fiber size and function in elderly humans: a 
54 
 
longitudinal study. Journal of Applied Physiology, 105(2), 637-642. doi: 
10.1152/japplphysiol.90332.2008 
Frontera, W. R., Suh, D., Krivickas, L. S., Hughes, V. A., Goldstein, R., & Roubenoff, R. 
(2000). Skeletal muscle fiber quality in older men and women. American Journal 
of Physiology - Cell Physiology, 279(3), C611-C618.  
Fukunaga, T., Miyatani, M., Tachi, M., Kouzaki, M., Kawakami, Y., & Kanehisa, H. 
(2001). Muscle volume is a major determinant of joint torque in humans. Acta 
Physiologica Scandinavica, 172(4), 249-255. doi: 10.1046/j.1365-
201x.2001.00867.x 
Goodpaster, B. H., Carlson, C. L., Visser, M., Kelley, D. E., Scherzinger, A., Harris, T. 
B., . . . Newman, A. B. (2001). Attenuation of skeletal muscle and strength in the 
elderly: The Health ABC Study. Journal of Applied Physiology, 90(6), 2157-
2165.  
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, 
A. V., . . . Newman, A. B. (2006). The loss of skeletal muscle strength, mass, and 
quality in older adults: The health, Aging and Body Composition Study. The 
Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 
61(10), 1059-1064.  
Gordon, T., Hegedus, J., & Tam, S. L. (2004). Adaptive and maladaptive motor axonal 
sprouting in aging and motoneuron disease. Neurological Research, 26(2), 174-
185. doi: 10.1179/016164104225013806 
Götherström, G., Elbornsson, M., Stibrant-Sunnerhagen, K., Bengtsson, B.-Å., 
Johannsson, G., & Svensson, J. (2009). Ten years of growth hormone (GH) 
replacement normalizes muscle strength in GH-deficient adults. Journal of 
Clinical Endocrinology & Metabolism, 94(3), 809-816. doi: 10.1210/jc.2008-
1538 
55 
 
Greiwe, J. S., Cheng, B., Rubin, D. C., Yarasheski, K. E., & Semenkovich, C. F. (2001). 
Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail 
elderly humans. The FASEB Journal, 15(2), 475-482. doi: 10.1096/fj.00-0274com 
Griggs, R. C., Kingston, W., Jozefowicz, R. F., Herr, B. E., Forbes, G., & Halliday, D. 
(1989). Effect of testosterone on muscle mass and muscle protein synthesis. 
Journal of Applied Physiology, 66(1), 498-503.  
Grossman, R. I., Gomori, J. M., Ramer, K. N., Lexa, F. J., & Schnall, M. D. (1994). 
Magnetization transfer: theory and clinical applications in neuroradiology. 
Radiographics, 14(2), 279-290.  
Hairi, N. N., Cumming, R. G., Naganathan, V., Handelsman, D. J., Le Couteur, D. G., 
Creasey, H., . . . Sambrook, P. N. (2010). Loss of muscle strength, mass 
(sarcopenia), and quality (specific force) and its relationship with functional 
limitation and physical disability: The Concord Health and Ageing in Men 
Project. Journal of the American Geriatrics Society, 58(11), 2055-2062. doi: 
10.1111/j.1532-5415.2010.03145.x 
Häkkinen, K., Newton, R. U., Gordon, S. E., McCormick, M., Volek, J. S., Nindl, B. C., . 
. . Kraemer, W. J. (1998). Changes in muscle morphology, electromyographic 
activity, and force production characteristics during progressive strength training 
in young and older men. The Journals of Gerontology Series A: Biological 
Sciences and Medical Sciences, 53A(6), B415-B423. doi: 
10.1093/gerona/53A.6.B415 
Hameed, M., Harridge, S. D. R., & Goldspink, G. (2002). Sarcopenia and hypertrophy: A 
role for insulin-like growth factor-1 in aged muscle? Exercise and Sport Sciences 
Reviews, 30(1), 15-19.  
Hasten, D. L., Pak-Loduca, J., Obert, K. A., & Yarasheski, K. E. (2000). Resistance 
exercise acutely increases MHC and mixed muscle protein synthesis rates in 78–
84 and 23–32 yr olds. American Journal of Physiology - Endocrinology And 
Metabolism, 278(4), E620-E626.  
56 
 
Hawkins, S. A., Wiswell, R. A., & Marcell, T. J. (2003). Exercise and the Master 
athlete—A model of successful aging? The Journals of Gerontology Series A: 
Biological Sciences and Medical Sciences, 58(11), M1009-M1011. doi: 
10.1093/gerona/58.11.M1009 
He, J., Goodpaster, B. H., & Kelley, D. E. (2004). Effects of weight loss and physical 
activity on muscle lipid content and droplet size. Obesity, 12(5), 761-769.  
Henderson, G. C., Irving, B. A., & Nair, K. S. (2009). Potential application of essential 
amino acid supplementation to treat sarcopenia in elderly people. Journal of 
Clinical Endocrinology & Metabolism, 94(5), 1524-1526. doi: 10.1210/jc.2009-
0458 
Henkelman, R. M., Stanisz, G. J., & Graham, S. J. (2001). Magnetization transfer in 
MRI: A review. NMR in Biomedicine, 14(2), 57-64. doi: 10.1002/nbm.683 
Henneman, E. (1985). The size-principle: a deterministic output emerges from a set of 
probabilistic connections. Journal of Experimental Biology, 115(1), 105-112.  
Hennessey, J. V., Chromiak, J. A., DellaVentura, S., Reinert, S. E., Puhl, J., Kiel, D. P., . 
. . MacLean, D. B. (2001). Growth hormone administration and exercise effects 
on muscle fiber type and diameter in moderately frail older people. Journal of the 
American Geriatrics Society, 49(7), 852-858. doi: 10.1046/j.1532-
5415.2001.49173.x 
Hillsdon, M. M., Brunner, E. J., Guralnik, J. M., & Marmot, M. G. (2005). Prospective 
study of physical activity and physical function in early old age. American 
Journal of Preventive Medicine, 28(3), 245-250. doi: 
10.1016/j.amepre.2004.12.008 
Hiona, A., & Leeuwenburgh, C. (2008). The role of mitochondrial DNA mutations in 
aging and sarcopenia: Implications for the mitochondrial vicious cycle theory of 
aging. Experimental Gerontology, 43(1), 24-33. doi: 10.1016/j.exger.2007.10.001 
57 
 
Holeček, M., Šprongl, L., Tilšer, I., & Tichý, M. (2001). Leucine and protein metabolism 
in rats with chronic renal insufficiency. Experimental and Toxicologic Pathology, 
53(1), 71-76. doi: 10.1078/0940-2993-00171 
Holloszy, J. O., & Nair, K. S. (1995). Muscle protein turnover: Methodological issues 
and the effect of aging. The Journals of Gerontology Series A: Biological 
Sciences and Medical Sciences, 50A(Special Issue), 107-112. doi: 
10.1093/gerona/50A.Special_Issue.107 
Hortobágyi, T., Zheng, D., Weidner, M., Lambert, N. J., Westbrook, S., & Houmard, J. 
A. (1995). The influence of aging on muscle strength and muscle fiber 
characteristics with special reference to eccentric strength. The Journals of 
Gerontology Series A: Biological Sciences and Medical Sciences, 50A(6), B399-
B406. doi: 10.1093/gerona/50A.6.B399 
Houston, D. K., Nicklas, B. J., Ding, J., Harris, T. B., Tylavsky, F. A., Newman, A. B., . . 
. Study, f. t. H. A. (2008). Dietary protein intake is associated with lean mass 
change in older, community-dwelling adults: the Health, Aging, and Body 
Composition (Health ABC) Study. American Journal of Clinical Nutrition, 87(1), 
150-155.  
Hurley, B. F., Hanson, E. D., & Sheaff, A. K. (2011). Strength training as a 
countermeasure to aging muscle and chronic disease. Sports Medicine, 41(4), 
289-306. 
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002). Prevalence of 
sarcopenia and predictors of skeletal muscle mass in healthy, older men and 
women. The Journals of Gerontology Series A: Biological Sciences and Medical 
Sciences, 57(12), M772-M777. doi: 10.1093/gerona/57.12.M772 
Iranmanesh, A., Lizarralde, G., & Veldhuis, J. D. (1991). Age and relative adiposity are 
specific negative determinants of the frequency and amplitude of growth hormone 
(GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal 
58 
 
of Clinical Endocrinology & Metabolism, 73(5), 1081-1088. doi: 10.1210/jcem-
73-5-1081 
Jakobi, J. M., & Rice, C. L. (2001). Lower motor unit firing rates but no change in 
contractile properties in two upper limb muscles of old men. Medicine & Science 
in Sports & Exercise, 33(Suppl), S271.  
Janssen, I., Heymsfield, S. B., & Ross, R. (2002). Low relative skeletal muscle mass 
(sarcopenia) in older persons is associated with functional impairment and 
physical disability. Journal of the American Geriatrics Society, 50(5), 889-896. 
doi: 10.1046/j.1532-5415.2002.50216.x 
Janssen, I., Heymsfield, S. B., Wang, Z., & Ross, R. (2000). Skeletal muscle mass and 
distribution in 468 men and women aged 18–88 yr. Journal of Applied 
Physiology, 89(1), 81-88.  
Janssen, I., Shepard, D. S., Katzmarzyk, P. T., & Roubenoff, R. (2004). The healthcare 
costs of sarcopenia in the United States. Journal of the American Geriatrics 
Society, 52(1), 80-85. doi: 10.1111/j.1532-5415.2004.52014.x 
Jarosz, P. A., & Bellar, A. (2009). Sarcopenic obesity: An emerging cause of frailty in 
older adults. Geriatric Nursing, 30(1), 64-70. doi: 
10.1016/j.gerinurse.2008.02.010 
Jensen, G. L. (2008). Inflammation: Roles in aging and sarcopenia. Journal of Parenteral 
and Enteral Nutrition, 32(6), 656-659. doi: 10.1177/0148607108324585 
Johannsson, G., Grimby, G., Sunnerhagen, K. S., & Bengtsson, B.-Å. (1997). Two Years 
of Growth Hormone (GH) Treatment increase isometric and isokinetic muscle 
strength in GH-deficient adults. Journal of Clinical Endocrinology & Metabolism, 
82(9), 2877-2884. doi: 10.1210/jc.82.9.2877 
Johnson, M. A., Sideri, G., Weightman, D., & Appleton, D. (1973). A comparison of 
fibre size, fibre type constitution and spatial fibre type distribution in normal 
human muscle and in muscle from cases of spinal muscular atrophy and from 
59 
 
other neuromuscular disorders. Journal of the Neurological Sciences, 20(4), 345-
361. doi: 10.1016/0022-510x(73)90169-x 
Jubrias, S. A., Odderson, I. R., Esselman, P. C., & Conley, K. E. (1997). Decline in 
isokinetic force with age: muscle cross-sectional area and specific force. 
European Journal of Physiology, 434(3), 246-253. doi: 10.1007/s004240050392 
Kamath, S., Venkatanarasimha, N., Walsh, M., & Hughes, P. (2008). MRI appearance of 
muscle denervation. Skeletal Radiology, 37(5), 397-404. doi: 10.1007/s00256-
007-0409-0 
Kamel, H. K., Maas, D., & Duthie, E. H. J. (2002). Role of hormones in the pathogenesis 
and management of sarcopenia. Drugs & Aging, 19(11), 865-877.  
Katsanos, C. S., Kobayashi, H., Sheffield-Moore, M., Aarsland, A., & Wolfe, R. R. 
(2006). A high proportion of leucine is required for optimal stimulation of the rate 
of muscle protein synthesis by essential amino acids in the elderly. American 
Journal of Physiology - Endocrinology And Metabolism, 291(2), E381-E387. doi: 
10.1152/ajpendo.00488.2005 
Kent-Braun, J. A., & Ng, A. V. (1999). Specific strength and voluntary muscle activation 
in young and elderly women and men. Journal of Applied Physiology, 87(1), 22-
29.  
Kent-Braun, J. A., Ng, A. V., & Young, K. (2000). Skeletal muscle contractile and 
noncontractile components in young and older women and men. Journal of 
Applied Physiology, 88(2), 662-668.  
Kerr, J. F. R., Wyllie, A. H., & Curie, A. R. (1972). Apoptosis: a basic biological 
phenomenon with wide-ranging implications in tissue kinetics. British Journal of 
Cancer, 4, 239-257.  
Klein, C. S., Rice, C. L., & Marsh , G. D. (2001). Normalized force, activation, and 
coactivation in the arm muscles of young and old men. Journal of Applied 
Physiology, 91(3), 1341-1349.  
60 
 
Klitgaard, H., Mantoni, M., Schiaffino, S., Ausoni, S., Gorza, L., Laurent-Winter, C., . . . 
Saltin, B. (1990). Function, morphology and protein expression of ageing skeletal 
muscle: a cross-sectional study of elderly men with different training 
backgrounds. Acta Physiologica Scandinavica, 140(1), 41-54. doi: 
10.1111/j.1748-1716.1990.tb08974.x 
Knight, R. A., Nagesh, V., Nagaraja, T. N., Ewing, J. R., Whitton, P. A., Bershad, E., . . . 
Fenstermacher, J. D. (2005). Acute blood–brain barrier opening in experimentally 
induced focal cerebral ischemia is preferentially identified by quantitative 
magnetization transfer imaging. Magnetic Resonance in Medicine, 54(4), 822-
832. doi: 10.1002/mrm.20630 
Kosek, D. J., Kim, J.-s., Petrella, J. K., Cross, J. M., & Bamman, M. M. (2006). Efficacy 
of 3 days/wk resistance training on myofiber hypertrophy and myogenic 
mechanisms in young vs. older adults. Journal of Applied Physiology, 101(2), 
531-544. doi: 10.1152/japplphysiol.01474.2005 
Lang, T., Streeper, T., Cawthon, P., Baldwin, K., Taaffe, D., & Harris, T. (2010). 
Sarcopenia: etiology, clinical consequences, intervention, and assessment. 
Osteoporosis International, 21(4), 543-559. doi: 10.1007/s00198-009-1059-y 
Larsson, L., Grimby, G., & Karlsson, J. (1979). Muscle strength and speed of movement 
in relation to age and muscle morphology. Journal of Applied Physiology, 46(3), 
451-456.  
Lemasters, J. J. (2005). Selective mitochondrial autophagy, or mitophagy, as a targeted 
defense against oxidative stress, mitochondrial dysfunction, and aging. 
Rejuvenation Research, 8(1), 3-5.  
Leveille, S. G., Guralnik, J. M., Ferrucci, L., & Langlois, J. A. (1999). Aging 
successfully until death in old age: Opportunities for increasing active life 
expectancy. American Journal of Epidemiology, 149(7), 654-664.  
61 
 
Levine, J. A., Abboud, L., Barry, M., Reed, J. E., Sheedy, P. F., & Jensen, M. D. (2000). 
Measuring leg muscle and fat mass in humans: comparison of CT and dual-energy 
X-ray absorptiometry. Journal of Applied Physiology, 88(2), 452-456.  
Lexell, J. (1993). Ageing and Human Muscle: Observations from Sweden. Canadian 
Journal of Applied Physiology, 18(1), 2-18. doi: 10.1139/h93-002 
Lexell, J., & Downham, D. (1992). What determines the muscle cross-sectional area? 
Journal of the Neurological Sciences, 111(1), 113-114. doi: 10.1016/0022-
510x(92)90119-6 
Lexell, J., Taylor, C. C., & Sjostrom, M. (1988). What is the cause of the ageing atrophy? 
Total number, size and proportion of different fiber types studied in whole vastus 
lateralis muscle from 15- to 83-year-old men. Journal of the neurological 
sciences, 84(2-3), 275-294.  
Lumeng, C. N., DeYoung, S. M., Bodzin, J. L., & Saltiel, A. R. (2007). Increased 
inflammatory properties of adipose tissue macrophages tecruited during diet-
induced obesity. Diabetes, 56(1), 16-23. doi: 10.2337/db06-1076 
Manini, T. M., Clark, B. C., Nalls, M. A., Goodpaster, B. H., Ploutz-Snyder, L. L., & 
Harris, T. B. (2007). Reduced physical activity increases intermuscular adipose 
tissue in healthy young adults. American Journal of Clinical Nutrition, 85(2), 
377-384.  
Manini, T. M., Everhart, J. E., Anton, S. D., Schoeller, D. A., Cummings, S. R., Mackey, 
D. C., . . . Harris, T. B. (2009). Activity energy expenditure and change in body 
composition in late life. American Journal of Clinical Nutrition, 90(5), 1336-
1342. doi: 10.3945/ajcn.2009.27659 
Marzetti, E., & Leeuwenburgh, C. (2006). Skeletal muscle apoptosis, sarcopenia and 
frailty at old age. Experimental Gerontology, 41(12), 1234-1238. doi: 
10.1016/j.exger.2006.08.011 
62 
 
Mattila, K. T., Lukka, R., Hurme, T., Komu, M., Alanen, A., & Kalimo, H. (1995). 
Magnetic resonance imaging and magnetization transfer in experimental 
myonecrosis in the rat. Magnetic Resonance in Medicine, 33(2), 185-192. doi: 
10.1002/mrm.1910330207 
McCartney, N., McKelvie, R. S., Martin, J., Sale, D. G., & MacDougall, J. D. (1993). 
Weight-training-induced attenuation of the circulatory response of older males to 
weight lifting. Journal of Applied Physiology, 74(3), 1056-1060.  
McComas, A. J. (1991). Invited review: Motor unit estimation: Methods, results, and 
present status. Muscle & Nerve, 14(7), 585-597. doi: 10.1002/mus.880140702 
McDaniel, J. D., Ulmer, J. L., Prost, R. W., Franczak, M. B., Jaradeh, S., Hamilton, C. 
A., & Mark, L. P. (1999). Magnetization transfer imaging of skeletal muscle in 
autosomal recessive limb girdle muscular dystrophy. Journal of Computer 
Assisted Tomography, 23(4), 609-614.  
McNeil, C. J., Doherty, T. J., Stashuk, D. W., & Rice, C. L. (2005a). The effect of 
contraction intensity on motor unit number estimates of the tibialis anterior. 
Clinical Neurophysiology, 116(6), 1342-1347. doi: 10.1016/j.clinph.2005.02.006 
McNeil, C. J., Doherty, T. J., Stashuk, D. W., & Rice, C. L. (2005b). Motor unit number 
estimates in the tibialis anterior muscle of young, old, and very old men. Muscle 
& Nerve, 31(4), 461-467. doi: 10.1002/mus.20276 
McNeil, C. J., Vandervoort, A. A., & Rice, C. L. (2007). Peripheral impairments cause a 
progressive age-related loss of strength and velocity-dependent power in the 
dorsiflexors. Journal of Applied Physiology, 102(5), 1962-1968. doi: 
10.1152/japplphysiol.01166.2006 
Melov, S., Tarnopolsky, M. A., Beckman, K., Felkey, K., & Hubbard, A. (2007). 
Resistance exercise reverses aging in human skeletal muscle: Public Library of 
Science. 
63 
 
Messier, V., Rabasa-Lhoret, R., Barbat-Artigas, S., Elisha, B., Karelis, A. D., & 
Aubertin-Leheudre, M. (2011). Menopause and sarcopenia: A potential role for 
sex hormones. Maturitas, 68(4), 331-336. doi: 10.1016/j.maturitas.2011.01.014 
Mittal, K. R., & Logmani, F. H. (1987). Age-related reduction in 8th cervical ventral 
nerve root myelinated fiber diameters and numbers in man. Journal of 
Gerontology, 42(1), 8-10. doi: 10.1093/geronj/42.1.8 
Morais, J. A., Chevalier, S., & Gougeon, R. (2006). Protein turnover and requirements in 
the healthy and frail elderly. Journal of Nutrition, Health & Aging, 10(4), 272-
283.  
Morley, J. E. (2012). Sarcopenia in the elderly. Family Practice, 29(suppl 1), i44-i48. 
doi: 10.1093/fampra/cmr063 
Morley, J. E., Baumgartner, R. N., Roubenoff, R., Mayer, J., & Nair, K. S. (2001). 
Sarcopenia. Journal of Laboratory and Clinical Medicine, 137(4), 231-243.  
Morley, J. E., Haren, M. T., Kim, M. J., Kevorkian, R., & Perry, H. M. (2005). 
Testosterone, aging and quality of life. Journal of Endocrinological Investigation, 
28(3 Suppl), 76-80.  
Morse, C. I., Thom, J., Mian, O., Muirhead, A., Birch, K., & Narici, M. (2005). Muscle 
strength, volume and activation following 12-month resistance training in 70-
year-old males. European Journal of Applied Physiology, 95(2), 197-204. doi: 
10.1007/s00421-005-1342-3 
Morse, C. I., Thom, J. M., Birch, K. M., & Narici, M. V. (2005). Changes in triceps surae 
muscle architecture with sarcopenia. Acta Physiologica Scandinavica, 183(3), 
291-298. doi: 10.1111/j.1365-201X.2004.01404.x 
Mühlberg, W., & Sieber, C. (2004). Sarcopenia and frailty in geriatric patients: 
Implications for training and prevention. Zeitschrift für Gerontologie und 
Geriatrie, 37(1), 2-8. doi: 10.1007/s00391-004-0203-8 
64 
 
Murga Oporto, L., Menendez-de Leon, C., Bauzano Poley, E., & Nunez-Castain, M. J. 
(2003). Statistical (Poisson) motor unit number estimation. Methodological 
aspects and normal results in the extensor digitorum brevis muscle of healthy 
subjects. Revista de Neurologia, 36(7), 601-604.  
Narici, M. V., & Maffulli, N. (2010). Sarcopenia: characteristics, mechanisms and 
functional significance. British Medical Bulletin, 95(1), 139-159. doi: 
10.1093/bmb/ldq008 
Narici, M. V., Maffulli, N., & Maganaris, C. N. (2008). Ageing of human muscles and 
tendons. Disability and Rehabilitation, 30(20-22), 1548-1554. doi: 
doi:10.1080/09638280701831058 
Narici, M. V., Maganaris, C. N., Reeves, N. D., & Capodaglio, P. (2003). Effect of aging 
on human muscle architecture. Journal of Applied Physiology, 95(6), 2229-2234. 
doi: 10.1152/japplphysiol.00433.2003 
Narici, M. V., Roi, G., Landoni, L., Minetti, A., & Cerretelli, P. (1989). Changes in force, 
cross-sectional area and neural activation during strength training and detraining 
of the human quadriceps. European Journal of Applied Physiology and 
Occupational Physiology, 59(4), 310-319. doi: 10.1007/bf02388334 
Nass, R., Johannsson, G., Christiansen, J. S., Kopchick, J. J., & Thorner, M. O. (2009). 
The aging population – Is there a role for endocrine interventions? Growth 
Hormone, 19(2), 89-100. doi: 10.1016/j.ghir.2008.09.002 
Neels, J. G., & Olefsky, J. M. (2006). Inflamed fat: what starts the fire? Journal of 
Clinical Investigation, 116(1), 33-35.  
Newman, A. B., Haggerty, C. L., Goodpaster, B., Harris, T., Kritchevsky, S., Nevitt, M., . 
. . Body Composition Research, G. (2003). Strength and muscle quality in a well-
functioning cohort of older adults: The Health, Aging and Body Composition 
Study. Journal of the American Geriatrics Society, 51(3), 323-330. doi: 
10.1046/j.1532-5415.2003.51105.x 
65 
 
Paddon-Jones, D., & Rasmussen, B. B. (2009). Dietary protein recommendations and the 
prevention of sarcopenia. Current Opinion in Clinical Nutrition & Metabolic 
Care, 12(1), 86-90 10.1097/MCO.1090b1013e32831cef32838b.  
Pahor, M., Manini, T., & Cesari, M. (2009). Sarcopenia: Clinical evaluation, biological 
markers and other evaluation tools. Journal of Nutrition, Health & Aging, 13(8), 
724-728. doi: 10.1007/s12603-009-0204-9 
Pai, Y.-C., & Bhatt, T. S. (2007). Repeated-slip training: An emerging paradigm for 
prevention of slip-related falls among older adults. Physical Therapy, 87(11), 
1478-1491. doi: 10.2522/ptj.20060326 
Pearson, S. J., Young, A., Macaluso, A., Devito, G., Nimmo, M. A., Cobbold, M., & 
Harridge, S. D. R. (2002). Muscle function in elite master weightlifters. Medicine 
& Science in Sports & Exercise, 34(7), 1199-1206.  
Perry, H. M., Miller, D. K., Patrick, P., & Morley, J. E. (2000). Testosterone and leptin in 
older African-American men: Relationship to age, strength, function, and season. 
Metabolism, 49(8), 1085-1091. doi: 10.1053/meta.2000.7710 
Porter, M. M., Vandervoort, A. A., & Lexell, J. (1995). Aging of human muscle: 
structure, function and adaptability. Scandinavian Journal of Medicine & Science 
in Sports, 5(3), 129-142. doi: 10.1111/j.1600-0838.1995.tb00026.x 
Power, G. A., Dalton, B. H., Behm, D. G., Doherty, T. J., Vandervoort, A. A., & Rice, C. 
L. (2012). Motor unit survival in life-long runners is muscle-dependent. Medicine 
& Science in Sports & Exercise, Published Ahead of Print, 
10.1249/MSS.1240b1013e318249953c.  
Power, G. A., Dalton, B. H., Behm, D. G., Vandervoort, A. A., Doherty, T. J., & Rice, C. 
L. (2010). Motor unit number rstimates in Masters runners: Use it or lose it? 
Medicine & Science in Sports & Exercise, 42(9), 1644-1650 
1610.1249/MSS.1640b1013e3181d1646f1649e1649.  
66 
 
Reaven, G. M. (1988). Banting lecture 1988. Role of insulin resistance in human disease. 
Diabetes, 37(12), 1595-1607.  
Roos, M. R., Rice, C. L., & Vandervoort, A. A. (1997). Age-related changes in motor 
unit function. [10.1002/(SICI)1097-4598(199706)20:6<679::AID-
MUS4>3.0.CO;2-5]. Muscle & Nerve, 20(6), 679-690.  
Rosenberg, I. H. (1989). Summary comments. American Journal of Clinical Nutrition, 
50(5), 1231-1233.  
Roth, S. M., Ferrell, R. F., & Hurley, B. F. (2000). Strength training for the prevention 
and treatment of sarcopenia. Journal of Nutrition, Health & Aging, 4(3), 143-155.  
Roth, S. M., Martel, G. F., Ivey, F. M., Lemmer, J. T., Tracy, B. L., Metter, E. J., . . . 
Rogers, M. A. (2001). Skeletal muscle satellite cell characteristics in young and 
older men and women after heavy resistance strength training. The Journals of 
Gerontology Series A: Biological Sciences and Medical Sciences, 56(6), B240-
B247. doi: 10.1093/gerona/56.6.B240 
Roth, S. M., Metter, E. J., Ling, S., & Ferrucci, L. (2006). Inflammatory factors in age-
related muscle wasting. Current Opinion in Rheumatology, 18(6), 625-630 
610.1097/1001.bor.0000245722.0000210136.0000245726d.  
Roubenoff, R. (2000a). Sarcopenia and its implications for the elderly. European Journal 
of Clinical Nutrition, 54(6), S40.  
Roubenoff, R. (2000b). Sarcopenia: a major modifiable cause of frailty in the elderly. 
Journal of Nutrition Health & Aging, 4(3), 140-142.  
Roubenoff, R. (2000c). Sarcopenic obesity: Does muscle loss cause fat gain?: Lessons 
from rheumatoid arthritis and osteoarthritisa. Annals of the New York Academy of 
Sciences, 904(1), 553-557. doi: 10.1111/j.1749-6632.2000.tb06515.x 
Roubenoff, R. (2001). Origins and clinical relevance of sarcopenia. Canadian Journal of 
Applied Physiology, 26(1), 78-89. doi: 10.1139/h01-006 
67 
 
Roubenoff, R. (2004). Sarcopenic obesity: The confluence of two epidemics. Obesity, 
12(6), 887-888.  
Roubenoff, R., & Hughes, V. A. (2000). Sarcopenia: current concepts. The Journals of 
Gerontology Series A: Biological Sciences and Medical Sciences, 55(12), M716-
M724. doi: 10.1093/gerona/55.12.M716 
Ryan, A. S., Dobrovolny, C. L., Smith, G. V., Silver, K. H., & Macko, R. F. (2002). 
Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. 
Archives of Physical Medicine and Rehabilitation, 83(12), 1703-1707. doi: 
10.1053/apmr.2002.36399 
Ryazanov, A. G., & Nefsky, B. S. (2002). Protein turnover plays a key role in aging. 
Mechanisms of Ageing and Development, 123(2–3), 207-213. doi: 10.1016/s0047-
6374(01)00337-2 
Sara, V. R., & Hall, K. (1990). Insulin-like growth factors and their binding proteins. 
Physiological Reviews, 70(3), 591-614.  
Sattler, F. R., Castaneda-Sceppa, C., Binder, E. F., Schroeder, E. T., Wang, Y., Bhasin, 
S., . . . Azen, S. P. (2009). Testosterone and growth hormone improve body 
composition and muscle performance in older men. Journal of Clinical 
Endocrinology & Metabolism, 94(6), 1991-2001. doi: 10.1210/jc.2008-2338 
Schaap, L. A., Pluijm, S. M. F., Deeg, D. J. H., & Visser, M. (2006). Inflammatory 
markers and loss of muscle mass (sarcopenia) and strength. American Journal of 
Medicine, 119(6), 526.e529-526.e517. doi: 10.1016/j.amjmed.2005.10.049 
Schwenzer, N. F., Martirosian, P., Machann, J., Schraml, C., Steidle, G., Claussen, C. D., 
& Schick, F. (2009). Aging effects on human calf muscle properties assessed by 
MRI at 3 Tesla. Journal of Magnetic Resonance Imaging, 29(6), 1346-1354. doi: 
10.1002/jmri.21789 
Sinclair, C. D. J., Morrow, J. M., Miranda, M. A., Davagnanam, I., Cowley, P. C., Mehta, 
H., . . . Thornton, J. S. (2012). Skeletal muscle MRI magnetisation transfer ratio 
68 
 
reflects clinical severity in peripheral neuropathies. Journal of Neurology, 
Neurosurgery & Psychiatry, 83(1), 29-32. doi: 10.1136/jnnp.2011.246116 
Sinclair, C. D. J., Samson, R. S., Thomas, D. L., Weiskopf, N., Lutti, A., Thornton, J. S., 
& Golay, X. (2010). Quantitative magnetization transfer in in vivo healthy human 
skeletal muscle at 3 T. Magnetic Resonance in Medicine, 64(6), 1739-1748. doi: 
10.1002/mrm.22562 
Skelton, D. A., Kennedy, J., & Rutherford, O. M. (2002). Explosive power and 
asymmetry in leg muscle function in frequent fallers and non‐fallers aged over 65. 
Age and Ageing, 31(2), 119-125. doi: 10.1093/ageing/31.2.119 
Sood, N., Baker, W. L., & Coleman, C. I. (2008). Effect of glucomannan on plasma lipid 
and glucose concentrations, body weight, and blood pressure: systematic review 
and meta-analysis. American Journal of Clinical Nutrition, 88(4), 1167-1175.  
Stålberg, E. (1980). Macro EMG, a new recording technique. Journal of Neurology, 
Neurosurgery & Psychiatry, 43(6), 475-482. doi: 10.1136/jnnp.43.6.475 
Stashuk, D. W. (1999). Detecting single fiber contributions to motor unit action 
potentials. Muscle & Nerve, 22(2), 218-229. doi: 10.1002/(sici)1097-
4598(199902)22:2<218::aid-mus10>3.0.co;2-s 
Stashuk, D. W., Doherty, T. J., & Brown, W. F. (2003). MUNE using decomposition-
enhanced spike-triggered averaging. In B. B. Mark (Ed.), Supplements to Clinical 
Neurophysiology (Vol. Volume 55, pp. 108-121): Elsevier. 
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. 
(2008). Sarcopenic obesity: definition, cause and consequences. Current Opinion 
in Clinical Nutrition & Metabolic Care, 11(6), 693-700 
610.1097/MCO.1090b1013e328312c328337d.  
Taaffe, D. R., Henwood, T. R., Nalls, M. A., Walker, D. G., Lang, T. F., & Harris, T. B. 
(2009). Alterations in muscle attenuation following detraining and retraining in 
69 
 
resistance-trained older adults. Gerontology, 55, 217-223. doi: 
10.1159/000182084 
Tenover, J. L. (1997). Testosterone and the aging male. Journal of Andrology, 18(2), 
103-106.  
Tenover, J. S., Matsumoto, A. M., Plymate, S. R., & Bremner, W. J. (1987). The effects 
of aging in normal men on bioavailable testosterone and luteinizing hormone 
secretion: Response to clomiphene citrate. Journal of Clinical Endocrinology & 
Metabolism, 65(6), 1118-1126. doi: 10.1210/jcem-65-6-1118 
Tinetti, M. E. (2003). Preventing falls in elderly persons. New England Journal of 
Medicine, 348(1), 42-49. doi: doi:10.1056/NEJMcp020719 
Toda, Y., & Kobayashi, T. (2000). The usefulness of walking for preventing sarcopenia 
in dieting postmenopausal women complaining of knee pain. Annals of the New 
York Academy of Sciences, 904(1), 610-613. doi: 10.1111/j.1749-
6632.2000.tb06524.x 
Tomlinson, B. E., & Irving, D. (1977). The numbers of limb motor neurons in the human 
lumbosacral cord throughout life. Journal of the Neurological Sciences, 34(2), 
213-219. doi: 10.1016/0022-510x(77)90069-7 
Trappe, S., Williamson, D., & Godard, M. (2002). Maintenance of whole muscle strength 
and size following resistance training in older men. The Journals of Gerontology 
Series A: Biological Sciences and Medical Sciences, 57(4), B138-B143. doi: 
10.1093/gerona/57.4.B138 
Ulmer, J. L., Logani, S. C., Mark, L. P., Hamilton, C. A., Prost, R. W., & Garman, J. N. 
(1998). Near-resonance saturation pulse imaging of the extraocular muscles in 
thyroid-related ophthalmopathy. American Journal of Neuroradiology, 19(5), 
943-950.  
Vandervoort, A. A. (2002). Aging of the human neuromuscular system. Muscle & Nerve, 
25(1), 17-25. doi: 10.1002/mus.1215 
70 
 
Vandervoort, A. A. (1992). Effects of ageing on human neuromuscular function: 
implications for exercise. Canadian Journal of Sport Sciences, 17(3), 178-184.  
Vandervoort, A. A., Kramer, J. F., & Wharram, E. R. (1990). Eccentric knee strength of 
elderly females. Journal of Gerontology, 45(4), B125-B128. doi: 
10.1093/geronj/45.4.B125 
Vandervoort, A. A., & McComas, A. J. (1986). Contractile changes in opposing muscles 
of the human ankle joint with aging. Journal of Applied Physiology, 61(1), 361-
367.  
Vandervoort, A. A., & Symons, T. B. (2001). Functional and metabolic consequences of 
sarcopenia. Canadian Journal of Applied Physiology, 26(1), 90-101. doi: 
10.1139/h01-007 
Vella, C. A., & Kravitz, L. (2002). Sarcopenia: The mystery of muscle loss. IDEA 
Personal Trainer, 13(4), 30-35.  
Vellas, B. J., Wayne, S. J., Garry, P. J., & Baumgartner, R. N. (1998). A two-year 
longitudinal study of falls in 482 community-dwelling elderly adults. The 
Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 
53A(4), M264-M274. doi: 10.1093/gerona/53A.4.M264 
Vermeulen, A., Goemaere, S., & Kaufman, J. M. (1999). Testosterone, body composition 
and aging. Journal of Endocrinological Investigation, 22(5 Suppl), 110-116.  
Vermeulen, A., & Kaufman, J. M. (1995). Ageing of the hypothalamo-pituitary- 
testicular axis in men. Hormone Research in Paediatrics, 43(1-3), 25-28.  
Vetta, F., Ronzoni, S., Taglieri, G., & Bollea, M. R. (1999). The impact of malnutrition 
on the quality of life in the elderly. Clinical Nutrition, 18(5), 259-267. doi: 
10.1016/s0261-5614(98)80022-8 
71 
 
Villareal, D. T., Banks, M., Siener, C., Sinacore, D. R., & Klein, S. (2004). Physical 
Frailty and Body Composition in Obese Elderly Men and Women. Obesity, 12(6), 
913-920.  
Visser, M., Goodpaster, B. H., Kritchevsky, S. B., Newman, A. B., Nevitt, M., Rubin, S. 
M., . . . Study, f. t. H. A. (2005). Muscle mass, muscle strength, and muscle fat 
infiltration as predictors of incident mobility limitations in well-functioning older 
persons. The Journals of Gerontology Series A: Biological Sciences and Medical 
Sciences, 60(3), 324-333. doi: 10.1093/gerona/60.3.324 
Visser, M., Harris, T. B., Langlois, J., Hannan, M. T., Roubenoff, R., Felson, D. T., . . . 
Kiel, D. P. (1998). Body fat and skeletal muscle mass in relation to physical 
disability in very old men and women of the Framingham Heart Study. The 
Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 
53A(3), M214-M221. doi: 10.1093/gerona/53A.3.M214 
Visser, M., Kritchevsky, S. B., Goodpaster, B. H., Newman, A. B., Nevitt, M., Stamm, 
E., & Harris, T. B. (2002). Leg muscle mass and composition in relation to lower 
extremity performance in men and women aged 70 to 79: The health, Aging and 
Body Composition Study. Journal of the American Geriatrics Society, 50(5), 897-
904. doi: 10.1046/j.1532-5415.2002.50217.x 
Visvanathan, R., & Chapman, I. M. (2009). Undernutrition and anorexia in the older 
person. Gastroenterology Clinics of North America, 38(3), 393-409. doi: 
10.1016/j.gtc.2009.06.009 
Volpi, E., Mittendorfer, B., Rasmussen, B. B., & Wolfe, R. R. (2000). The response of 
muscle protein anabolism to combined hyperaminoacidemia and glucose-induced 
hyperinsulinemia is impaired in the elderly. Journal of Clinical Endocrinology & 
Metabolism, 85(12), 4481-4490. doi: 10.1210/jc.85.12.4481 
Walsmith, J., & Roubenoff, R. (2002). Cachexia in rheumatoid arthritis. International 
Journal of Cardiology, 85(1), 89-99. doi: 10.1016/s0167-5273(02)00237-1 
72 
 
Waters, D. L., Baumgartner, R. N., & Garry, P. J. (2000). Sarcopenia: Current 
perspectives. Journal of Nutrition, Health & Aging, 4(3), 133-139.  
Wolff, S. D., & Balaban, R. S. (1994). Magnetization transfer imaging: practical aspects 
and clinical applications. Radiology, 192(3), 593-599.  
Yarasheski, K. E., Zachwieja, J. J., Campbell, J. A., & Bier, D. M. (1995). Effect of 
growth hormone and resistance exercise on muscle growth and strength in older 
men. American Journal of Physiology - Endocrinology And Metabolism, 268(2), 
E268-E276.  
Yoshioka, H., Takahashi, H., Onaya, H., Anno, I., Niitsu, M., & Itai, Y. (1994). Acute 
change of exercised muscle using magnetization transfer contrast MR imaging. 
Magnetic Resonance Imaging, 12(7), 991-997. doi: 10.1016/0730-
725x(94)91229-p 
Young, A., Stokes, M., & Crowe, M. (1984). Size and strength of the quadriceps muscles 
of old and young women. European Journal of Clinical Investigation, 14(4), 282-
287. doi: 10.1111/j.1365-2362.1984.tb01182.x 
Young, A., Stokes, M., & Crowe, M. (1985). The size and strength of the quadriceps 
muscles of old and young men. Clinical Physiology, 5(2), 145-154.  
Young, V. R. (1990). Amino acids and proteins in relation to the nutrition of elderly 
People. Age and Ageing, 19(Suppl), S10-S24. doi: 
10.1093/ageing/19.suppl_1.S10 
Yousem, D. M., Schnall, M. D., Dougherty, L., Weinstein, G. S., & Hayden, R. E. 
(1994). Magnetization transfer imaging of the head and neck: normative data. 
American Journal of Neuroradiology, 15(6), 1117-1121.  
Zachwieja, J. J., & Yarasheski, K. E. (1999). Does growth hormone therapy in 
conjunction with resistance exercise increase muscle force production and muscle 
mass in men and women Aged 60 Years or Older? Physical Therapy, 79(1), 76-
82.  
73 
 
Zhu, X. P., Zhao, S., & Isherwood, I. (1992). Magnetization transfer contrast (MTC) 
imaging of skeletal muscle at 0.26 Tesla — changes in signal intensity following 
exercise. British Journal of Radiology, 65(769), 39-43. doi: 10.1259/0007-1285-
65-769-39 
 
 
 
74 
 
Appendices 
Appendix A: MRI Subject Screening Questionnaire. 
 
75 
 
Appendix B: UWO Ethics Approval for MRI Research on Humans. 
 
 
76 
 
Appendix C: UWO Ethics Approval for Neuromuscular Research on Humans. 
 
77 
 
Curriculum Vitae 
 
Name:   William J. Booth 
 
Post-secondary Master of Science (Supervisor: Dr. Greg D Marsh) 
Education and The University of Western Ontario 
Degrees: London, Ontario, Canada 
  2010 – 2012 
 
Bachelor of Arts in Human Kinetics 
St. Francis Xavier University 
Antigonish, Nova Scotia, Canada 
2005 – 2010 
 
Honours and   Western Graduate Research Scholarship 
Awards:   2010 – 2012 
 
St. Francis Xavier University Dean’s List 
2009 – 2010  
 
Related Work  Teaching Assistant 
Experience Introductory Exercise Physiology 
  The University of Western Ontario 
2011 – 2012  
 
Publications: 
 
Harwood, B., Power, G.A., Allen, M.D., Booth, W.J. (2011). Tendon vibration does not 
alter decreased responsiveness of motoneurones in the absence of motor cortical 
input during fatigue. Journal of Physiology, 589(23):5559-5560. 
 
Booth, W.J., Allen, M.D., Power, G.A., Marsh, G.D., Rice, C.L. (2012). Motor unit loss 
precedes reductions in muscle viability in old and very old men: new insights into 
the progression of sarcopenia.  
 
Conference Presentations: 
 
Booth, W.J., Upshaw, A.N., Wilkinson, S.B., Lemon, P.W.R., Rice, C.L., Marsh, G.D. 
Resistance training induced similar hypertrophy in the arm and thigh musculature 
of young women. ACSM Annual Meeting, San Francisco, CA. 2012. Accepted. 
 
Booth, W.J., Barnett, M., Dalton, B.H., McNeil, C.J., Rice, C.L., Marsh, G.D. Leg 
muscle strength, area, and contraction velocity in young, old and very old women. 
Medicine & Science in Sports & Exercise, 43:S298. ACSM Annual Meeting, 
Denver, CO. 2011. 
